ATC TREE
By opening the major branch you get several minor branches.
For small molecule drugs, clicking the name will open the corresponding ChEMBL information page.
- A: ALIMENTARY TRACT AND METABOLISM DRUGS (627)
- A01: STOMATOLOGICAL PREPARATIONS (38)
- A01A: STOMATOLOGICAL PREPARATIONS (38)
- A01AA: Caries prophylactic agents (6)
- A01AB: Antiinfectives and antiseptics for local oral treatment (21)
- A01AC: Corticosteroids for local oral treatment (4)
- A01AD: Other agents for local oral treatment in ATC (7)
- A02: DRUGS FOR ACID RELATED DISORDERS (78)
- A02A: ANTACIDS (24)
- A02AA: antacids containing magnesium compounds (6)
- A02AB: antacids containing aluminium compounds (8)
- A02AC: antacids containing calcium compounds (3)
- A02AD: antacids containing combinations and complexes of aluminium, calcium and magnesium compounds (5)
- A02AF: Antacids with antiflatulents (2)
- A02AF01: Magaldrate and antiflatulents
- A02AF02: Ordinary salt combinations and antiflatulents
- A02AG: Antacids with antispasmodics (0)
- A02AH: Antacids with sodium bicarbonate (0)
- A02AX: Antacids, other combinations in ATC (0)
- A02B: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) (54)
- A02BA: Histamine H2 receptor antagonists for peptic ulcer and GORD (10)
- A02BB: Prostaglandin drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) (2)
- A02BC: Proton pump inhibitors for peptic ulcer and GORD (10)
- A02BD: Combinations for eradication of Helicobacter pylori (15)
- A02BD01: Omeprazole, amoxicillin and metronidazole
- A02BD02: Lansoprazole, tetracycline and metronidazole
- A02BD03: Lansoprazole, amoxicillin and metronidazole
- A02BD04: Pantoprazole, amoxicillin and clarithromycin
- A02BD05: Omeprazole, amoxicillin and clarithromycin
- A02BD06: Esomeprazole, amoxicillin and clarithromycin
- A02BD07: Lansoprazole, amoxicillin and clarithromycin
- A02BD08: Bismuth subcitrate, tetracycline and metronidazole
- A02BD09: Lansoprazole, clarithromycin and tinidazole
- A02BD10: Lansoprazole, amoxicillin and levofloxacin
- A02BD11: Pantoprazole, amoxicillin, clarithromycin and metronidazole
- A02BD12: Rabeprazole, amoxicillin and clarithromycin
- A02BD13: Rabeprazole, amoxicillin and metronidazole
- A02BD14: Vonoprazan, amoxicillin and clarithromycin
- A02BD15: Vonoprazan, amoxicillin and metronidazole
- A02BX: Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC (17)
- A02X: OTHER DRUGS FOR ACID RELATED DISORDERS in ATC (0)
- A03: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS (96)
- A03A: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS (54)
- A03AA: Synthetic anticholinergics, esters with tertiary amino group for functional gastrointestinal disorders (9)
- A03AB: Synthetic anticholinergics, quaternary ammonium compounds for functional gastrointestinal disorders (21)
- A03AC: Synthetic antispasmodics, amides with tertiary amines for functional gastrointestinal disorders (3)
- A03AD: Papaverine and derivatives containing drugs for functional gastrointestinal disorders (3)
- A03AE: Serotonin receptor antagonists for functional gastrointestinal disorders (2)
- A03AX: Other drugs for functional gastrointestinal disorders in ATC (16)
- A03B: BELLADONNA AND DERIVATIVES CONTAINING DRUGS, PLAIN FOR FUNCTIONAL GASTROINTESTINAL DISORDERS (9)
- A03BA: Belladonna alkaloids, tertiary amines for functional gastrointestinal disorders (3)
- A03BB: Belladonna alkaloids, semisynthetic, quaternary ammonium compounds for functional gastrointestinal disorders (6)
- A03C: ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS (16)
- A03CA: Synthetic anticholinergic agents in combination with psycholeptics (11)
- A03CA01: Isopropamide and psycholeptics
- A03CA02: Clidinium and psycholeptics
- A03CA03: Oxyphencyclimine and psycholeptics
- A03CA04: Otilonium bromide and psycholeptics
- A03CA05: Glycopyrronium bromide and psycholeptics
- A03CA06: Bevonium and psycholeptics
- A03CA07: Ambutonium and psycholeptics
- A03CA08: Diphemanil and psycholeptics
- A03CA09: Pipenzolate and psycholeptics
- A03CA30: Emepronium and psycholeptics
- A03CA34: Propantheline and psycholeptics
- A03CB: Belladonna and derivatives in combination with psycholeptics (5)
- A03CB01: Methylscopolamine and psycholeptics
- A03CB02: Belladonna total alkaloids and psycholeptics
- A03CB03: Atropine and psycholeptics
- A03CB04: Homatropine methylbromide and psycholeptics
- A03CB31: Hyoscyamine and psycholeptics
- A03CC: Other antispasmodics in combination with psycholeptics in ATC (0)
- A03D: ANTISPASMODICS IN COMBINATION WITH ANALGESICS (8)
- A03DA: Synthetic anticholinergic agents in combination with analgesics (7)
- A03DA01: Tropenzilone and analgesics
- A03DA02: Pitofenone and analgesics
- A03DA03: Bevonium and analgesics
- A03DA04: Ciclonium and analgesics
- A03DA05: Camylofin and analgesics
- A03DA06: Trospium and analgesics
- A03DA07: Tiemonium iodide and analgesics
- A03DB: Belladonna and derivatives in combination with analgesics (1)
- A03DB04: Butylscopolamine and analgesics
- A03DC: Other antispasmodics in combination with analgesics in ATC (0)
- A03E: ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS (0)
- A03EA: Antispasmodics, psycholeptics and analgesics in combination (0)
- A03ED: Antispasmodics in combination with other drugs (0)
- A03F: PROPULSIVES (9)
- A04: ANTIEMETICS AND ANTINAUSEANTS (17)
- A04A: ANTIEMETICS AND ANTINAUSEANTS (17)
- A04AA: Serotonin (5HT3) antagonists, antiemetics and antinauseants (6)
- A04AD: Other antiemetics in ATC (11)
- A05: BILE AND LIVER THERAPY DRUGS (15)
- A05A: BILE THERAPY DRUGS (8)
- A05AA: Bile acids and derivatives for bile therapy (4)
- A05AB: Preparations for biliary tract therapy (1)
- A05AX: Other drugs for bile therapy in ATC (3)
- A05B: LIVER THERAPY, LIPOTROPICS (7)
- A05BA: Liver therapy drugs (7)
- A05C: DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION (0)
- A06: DRUGS FOR CONSTIPATION (67)
- A06A: DRUGS FOR CONSTIPATION (67)
- A06AA: Softeners, emollients (3)
- A06AB: Contact laxatives (16)
- A06AC: Bulk-forming laxatives (10)
- A06AD: Osmotically acting laxatives (17)
- A06AG: Enema for Constipation (9)
- A06AH: Peripheral opioid receptor antagonists (5)
- A06AX: Other drugs for constipation in ATC (7)
- A07: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS (61)
- A07A: INTESTINAL ANTIINFECTIVES (23)
- A07AA: antibiotics, intestinal (15)
- A07AB: Sulfonamides, intestinal antiinfectives (3)
- A07AC: Imidazole derivatives, intestinal antiinfectives (1)
- A07AX: Other intestinal antiinfectives in ATC (4)
- A07B: INTESTINAL ADSORBENTS (9)
- A07BA: Charcoal preparations, intestinal absorbents (2)
- A07BB: Bismuth preparations, intestinal adsorbents (0)
- A07BC: Other intestinal adsorbents in ATC (7)
- A07C: ELECTROLYTES WITH CARBOHYDRATES, ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS (0)
- A07CA: Oral rehydration salt formulations (0)
- A07D: ANTIPROPULSIVES (8)
- A07DA: Antipropulsives (8)
- A07E: INTESTINAL ANTIINFLAMMATORY AGENTS (12)
- A07EA: Corticosteroids acting locally (7)
- A07EB: Antiallergic intestinal antiinflammatory drugs, excl. corticosteroids (1)
- A07EC: Aminosalicylic acid and similar agents (4)
- A07F: ANTIDIARRHEAL MICROORGANISMS (3)
- A07FA: Antidiarrheal microorganisms (3)
- A07FA01: Lactic acid producing organisms
- A07FA02: Saccharomyces boulardii
- A07FA51: Lactic acid producing organisms, combinations
- A07X: OTHER ANTIDIARRHEALS in ATC (6)
- A07XA: Other antidiarrheals in ATC (6)
- A08: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS (15)
- A08A: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS (15)
- A08AA: Centrally acting antiobesity products (13)
- A08AB: Peripherally acting antiobesity products (1)
- A08AX: Other antiobesity drugs in ATC (1)
- A09: DIGESTIVES, INCL. ENZYMES (10)
- A09A: DIGESTIVES, INCL. ENZYMES (10)
- A09AA: Enzyme preparations, digestives (4)
- A09AB: Acid preparations, digestives (4)
- A09AC: Enzyme and acid preparations, combinations (2)
- A09AC01: Pepsin and acid preparations
- A09AC02: Multienzymes and acid preparations
- A10: DRUGS USED IN DIABETES (105)
- A10A: INSULINS AND ANALOGUES (29)
- A10AB: Insulins and analogues for injection, fast-acting (7)
- A10AC: Insulins and analogues for injection, intermediate-acting (5)
- A10AD: Insulins and analogues for injection used in Diabetes, intermediate- or long-acting combined with fast-acting (7)
- A10AE: Insulins and analogues for injection, long-acting (9)
- A10AF: Insulins and analogues for inhalation (1)
- A10B: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS (75)
- A10BA: biguanide blood glucose lower drugs (3)
- A10BB: Sulfonylureas for blood glucose lowering (13)
- A10BC: Sulfonamides (heterocyclic), blood glucose lowering drugs (1)
- A10BD: Combinations of oral blood glucose lowering drugs (25)
- A10BD01: Phenformin and sulfonylureas
- A10BD02: Metformin and sulfonylureas
- A10BD03: Metformin and rosiglitazone
- A10BD04: Glimepiride and rosiglitazone
- A10BD05: Metformin and pioglitazone
- A10BD06: Glimepiride and pioglitazone
- A10BD07: Metformin and sitagliptin
- A10BD08: Metformin and vildagliptin
- A10BD09: Pioglitazone and alogliptin
- A10BD10: Metformin and saxagliptin
- A10BD11: Metformin and linagliptin
- A10BD12: Pioglitazone and sitagliptin
- A10BD13: Metformin and alogliptin
- A10BD14: Metformin and repaglinide
- A10BD15: Metformin and dapagliflozin
- A10BD16: Metformin and canagliflozin
- A10BD17: Metformin and acarbose
- A10BD18: Metformin and gemigliptin
- A10BD19: Linagliptin and empagliflozin
- A10BD20: Metformin and empagliflozin
- A10BD21: Saxagliptin and dapagliflozin
- A10BD22: Metformin and evogliptin
- A10BD23: Metformin and ertugliflozin
- A10BD24: Sitagliptin and ertugliflozin
- A10BD25: Metformin, saxagliptin and dapagliflozin
- A10BF: Alpha glucosidase inhibitors, blood glucose lowering (3)
- A10BG: Thiazolidinediones, blood glucose lowering drugs (3)
- A10BH: Dipeptidyl peptidase 4 (DPP-4) inhibitors for blood glucose lowering (9)
- A10BJ: Glucagon-like peptide-1 (GLP-1) analogues (6)
- A10BK: Sodium-glucose co-transporter 2 (SGLT2) inhibitors (6)
- A10BX: Other blood glucose lowering drugs, excl. insulins in ATC (6)
- A10X: OTHER DRUGS USED IN DIABETES in ATC (1)
- A10XA: Aldose reductase inhibitors used in diabetes (1)
- A11: VITAMINS (30)
- A11A: MULTIVITAMINS, COMBINATIONS (4)
- A11AA: Multivitamins with minerals (4)
- A11AA01: Multivitamins and iron
- A11AA02: Multivitamins and calcium
- A11AA03: Multivitamins and other minerals, incl. combinations
- A11AA04: Multivitamins and trace elements
- A11AB: Multivitamins, other combinations (0)
- A11B: MULTIVITAMINS, PLAIN (0)
- A11BA: Multivitamins, plain (0)
- A11C: VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO (10)
- A11CA: Vitamin A, plain (2)
- A11CB: Vitamin A and D in combination (0)
- A11CC: Vitamin D and analogues (8)
- A11D: VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 (3)
- A11DA: Vitamin B1, plain (3)
- A11DB: Vitamin B1 in combination with vitamin B6 and/or vitamin B12 (0)
- A11E: VITAMIN B-COMPLEX, INCL. COMBINATIONS (0)
- A11EA: Vitamin B-complex, plain (0)
- A11EB: Vitamin B-complex with vitamin C (0)
- A11EC: Vitamin B-complex with minerals (0)
- A11ED: Vitamin B-complex with anabolic steroids (0)
- A11EX: Vitamin B-complex, other combinations (0)
- A11G: ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS (2)
- A11GA: vitamin C products, plain (1)
- A11GB: vitamin C combinations (1)
- A11GB01: Ascorbic acid and calcium
- A11H: OTHER PLAIN VITAMIN PREPARATIONS in ATC (11)
- A11HA: Other plain vitamin preparations in ATC (11)
- A11J: OTHER VITAMIN PRODUCTS, COMBINATIONS in ATC (0)
- A11JA: Combinations of vitamins (0)
- A11JB: Vitamins with minerals (0)
- A11JC: Vitamins, other combinations (0)
- A12: MINERAL SUPPLEMENTS (42)
- A12A: CALCIUM SUPPLEMENTS (14)
- A12AA: Calcium (14)
- A12AX: Calcium, combinations with vitamin D and/or other drugs (0)
- A12B: POTASSIUM SUPPLEMENTS (7)
- A12C: OTHER MINERAL SUPPLEMENTS in ATC (21)
- A12CA: Sodium supplements (2)
- A12CB: Zinc Supplements (3)
- A12CC: Magnesium supplements, alimentary tract and metabolism (11)
- A12CD: Fluoride supplements (3)
- A12CE: Selenium supplements (2)
- A12CX: Other mineral products in ATC (0)
- A13: TONICS (0)
- A14: ANABOLIC AGENTS FOR SYSTEMIC USE (12)
- A14A: ANABOLIC STEROIDS (12)
- A14AA: Androstan derivatives (9)
- A14AB: Estren derivatives, systemic (3)
- A14B: OTHER ANABOLIC AGENTS in ATC (0)
- A15: APPETITE STIMULANTS (0)
- A16: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC (41)
- A16A: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC (41)
- A16AA: Amino acids and derivatives (7)
- A16AB: Enzymes for ALIMENTARY TRACT AND METABOLISM (19)
- A16AX: Various alimentary tract and metabolism products (15)
- B: BLOOD AND BLOOD FORMING ORGAN DRUGS (241)
- B01: ANTITHROMBOTIC AGENTS (75)
- B01A: ANTITHROMBOTIC AGENTS (75)
- B01AA: Vitamin K antagonists (10)
- B01AB: Heparin group antithrombotic drugs (12)
- B01AC: Platelet aggregation inhibitors excl. heparin (26)
- B01AD: Enzymes, antithrombotic (12)
- B01AE: Direct thrombin inhibitors (7)
- B01AF: Direct factor Xa inhibitors (4)
- B01AX: Other antithrombotic agents in ATC (4)
- B02: ANTIHEMORRHAGICS (41)
- B02A: ANTIFIBRINOLYTICS (7)
- B02AA: Antifibrinolytic amino acids (3)
- B02AB: Proteinase inhibitors, antifibrinolytic (4)
- B02B: VITAMIN K AND OTHER HEMOSTATICS (34)
- B02BA: Vitamin K containing hemostatics (2)
- B02BB: Fibrinogen containing hemostatics (1)
- B02BC: Local hemostatics (9)
- B02BD: Blood coagulation factors (13)
- B02BD01: Coagulation factor IX, II, VII and X in combination
- B02BD02: Coagulation factor VIII
- B02BD03: Factor VIII inhibitor bypassing activity
- B02BD04: Coagulation factor IX
- B02BD05: Coagulation factor VII
- B02BD06: Von Willebrand factor and coagulation factor VIII in combination
- B02BD07: Coagulation factor XIII
- B02BD08: Coagulation factor VIIa
- B02BD10: Von Willebrand factor
- B02BD11: Catridecacog
- B02BD13: Coagulation factor X
- B02BD14: Susoctocog alfa
- B02BD30: Thrombin
- B02BX: Other systemic hemostatics in ATC (9)
- B03: ANTIANEMIC PREPARATIONS (45)
- B03A: IRON ANTIANEMIC PREPARATIONS (30)
- B03AA: Iron bivalent, oral antianemic preparations (12)
- B03AB: Iron trivalent, oral antianemic preparations (9)
- B03AC: Iron, parenteral antianemic preparations (0)
- B03AD: Iron in combination with folic acid (4)
- B03AE: Iron in other combinations (5)
- B03AE01: Iron, vitamin B12 and folic acid
- B03AE02: Iron, multivitamins and folic acid
- B03AE03: Iron and multivitamins
- B03AE04: Iron, multivitamins and minerals
- B03AE10: Iron in various other combinations
- B03B: VITAMIN B12 AND FOLIC ACID (9)
- B03BA: Vitamin B12 (cyanocobalamin and analogues) (7)
- B03BB: Folic acid and derivatives as antianemics (2)
- B03X: OTHER ANTIANEMIC PREPARATIONS in ATC (6)
- B03XA: Other antianemic preparations in ATC (6)
- B05: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS (67)
- B05A: BLOOD AND RELATED PRODUCTS (13)
- B05AA: Blood substitutes and plasma protein fractions (9)
- B05AX: Other blood products in ATC (4)
- B05AX01: Erythrocytes
- B05AX02: Thrombocytes
- B05AX03: Blood plasma
- B05AX04: Stem cells from umbilical cord blood
- B05B: IV solutions used in parenteral administration of fluids, electrolytes and nutrients (11)
- B05BA: Solutions for parenteral nutrition (5)
- B05BA01: Amino acids
- B05BA02: Fat emulsions
- B05BA03: Carbohydrates
- B05BA04: Protein hydrolysates
- B05BA10: Combination solutions for parenteral nutrition
- B05BB: Solutions affecting the electrolyte balance (4)
- B05BB01: Electrolytes
- B05BB02: Electrolytes with carbohydrates
- B05BB03: Trometamol
- B05BB04: Electrolytes in combination with other drugs
- B05BC: Solutions producing osmotic diuresis (2)
- B05C: IRRIGATING SOLUTIONS, BLOOD SUBSTITUTES AND PERFUSION (20)
- B05CA: Antiinfective irrigating solutions (10)
- B05CB: Salt irrigating solutions (5)
- B05CX: Other irrigating solutions in ATC (5)
- B05D: PERITONEAL DIALYTICS (0)
- B05DA: Isotonic solutions, peritoneal dialysis (0)
- B05DB: Hypertonic solutions (0)
- B05X: I.V. SOLUTION ADDITIVES (23)
- B05XA: Electrolyte solutions (19)
- B05XB: Amino Acids, I.V. solution additive (3)
- B05XC: Vitamin IV solution additives (0)
- B05XX: Other i.v. solution additives in ATC (1)
- B05Z: HEMODIALYTICS AND HEMOFILTRATES (0)
- B05ZA: Hemodialytics, concentrates (0)
- B05ZB: Hemofiltrates (0)
- B06: OTHER HEMATOLOGICAL AGENTS in ATC (13)
- B06A: OTHER HEMATOLOGICAL AGENTS in ATC (13)
- B06AA: Enzymes, hematological (6)
- B06AB: Heme products (1)
- B06AC: Drugs used in hereditary angioedema (5)
- B06AX: Other hematological agents in ATC (1)
- C: CARDIOVASCULAR SYSTEM DRUGS (613)
- C01: CARDIAC THERAPY DRUGS (140)
- C01A: CARDIAC GLYCOSIDES (15)
- C01AA: Digitalis glycosides (10)
- C01AB: Scilla glycosides used in cardiac therapy (2)
- C01AC: Strophanthus glycosides used in cardiac therapy (2)
- C01AX: Other cardiac glycosides in ATC (1)
- C01B: ANTIARRHYTHMICS, CLASS I AND III (29)
- C01BA: Antiarrhythmics, class Ia (10)
- C01BB: Antiarrhythmics, class Ib (4)
- C01BC: Antiarrhythmics, class Ic (5)
- C01BD: Antiarrhythmics, class III (7)
- C01BG: Other antiarrhythmics, class I and III in ATC (3)
- C01C: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES (36)
- C01CA: Adrenergic and dopaminergic cardiac stimulants (28)
- C01CE: Phosphodiesterase inhibitors, cardiac stimulant (4)
- C01CX: Other cardiac stimulants in ATC (4)
- C01D: VASODILATORS USED IN CARDIAC DISEASES (42)
- C01DA: Organic nitrates used in cardiac disease (18)
- C01DB: Quinolone vasodilators used in cardiac diseases (1)
- C01DX: Other vasodilators used in cardiac diseases in ATC (23)
- C01E: OTHER CARDIAC PREPARATIONS in ATC (18)
- C01EA: Prostaglandin cardiac therapy preparations (1)
- C01EB: Other plain cardiac preparations in ATC (17)
- C01EX: Other cardiac therapy combination products in ATC (0)
- C02: ANTIHYPERTENSIVES (74)
- C02A: ANTIADRENERGIC AGENTS, CENTRALLY ACTING (17)
- C02AA: Rauwolfia alkaloids, centrally acting antiadrenergic (10)
- C02AB: Methyldopa, centrally acting adntiadrenergic agents (2)
- C02AC: Imidazoline receptor agonists (5)
- C02B: ANTIADRENERGIC AGENTS, GANGLION-BLOCKING (2)
- C02BA: Sulfonium derivatives, ganglion-blocking adreneregic (1)
- C02BB: Secondary and tertiary amines, ganglion-blocking antiadrenergic (1)
- C02BC: Bisquaternary ammonium compounds, ganglion-blocking antiandrenergic (0)
- C02C: ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING (12)
- C02CA: Alpha-adrenoreceptor antagonists, peripherally acting (5)
- C02CC: Guanine derivatives, peripherally acting antiadrenergic agents (7)
- C02D: ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON (8)
- C02DA: Thiazide derivatives acting on arteriolar smooth muscle (1)
- C02DB: Hydrazinophthalazine derivatives acting on arteriolar smooth muscle (4)
- C02DC: Pyrimidine derivatives acting on arteriolar smooth muscle (1)
- C02DD: Nitroferricyanide derivatives acting on arteriolar smooth muscle (1)
- C02DG: Guanine derivatives acting on arteriolar smooth muscle (1)
- C02K: OTHER ANTIHYPERTENSIVES in ATC (10)
- C02KA: Alkaloids, excl. rauwolfia, antihypertensives (1)
- C02KB: Tyrosine hydroxylase inhibitors, antihypertensives (1)
- C02KC: MAO inhibitors, antihypertensives (1)
- C02KD: Serotonin antagonists, antihypertensives (1)
- C02KX: Antihypertensives for pulmonary arterial hypertension (6)
- C02L: ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION (25)
- C02LA: Rauwolfia alkaloids and diuretics in combination (11)
- C02LA01: Reserpine and diuretics
- C02LA02: Rescinnamine and diuretics
- C02LA03: Deserpidine and diuretics
- C02LA04: Methoserpidine and diuretics
- C02LA07: Bietaserpine and diuretics
- C02LA08: Rauwolfia alkaloids, whole root and diuretics
- C02LA09: Syrosingopine and diuretics
- C02LA50: Combination of rauwolfia alkaloids and diuretics incl. other combinations
- C02LA51: Reserpine and diuretics, combinations with other drugs
- C02LA52: Rescinnamine and diuretics, combinations with other drugs
- C02LA71: Reserpine and diuretics, combinations with psycholeptics
- C02LB: Methyldopa and diuretics in combination (1)
- C02LB01: Methyldopa (levorotatory) and diuretics
- C02LC: Imidazoline receptor agonists in combination with diuretics (3)
- C02LC01: Clonidine and diuretics
- C02LC05: Moxonidine and diuretics
- C02LC51: Clonidine and diuretics, combinations with other drugs
- C02LE: Alpha-adrenoreceptor antagonists and diuretics (1)
- C02LE01: Prazosin and diuretics
- C02LF: Guanidine derivatives and diuretics (1)
- C02LF01: Guanethidine and diuretics
- C02LG: Hydrazinophthalazine derivatives and diuretics (5)
- C02LG01: Dihydralazine and diuretics
- C02LG02: Hydralazine and diuretics
- C02LG03: Picodralazine and diuretics
- C02LG51: Dihydralazine and diuretics, combinations with other drugs
- C02LG73: Picodralazine and diuretics, combinations with psycholeptics
- C02LK: Alkaloids, excl. rauwolfia, in combination with diuretics (1)
- C02LK01: Veratrum and diuretics
- C02LL: MAO inhibitors and diuretics (1)
- C02LL01: Pargyline and diuretics
- C02LN: Serotonin antagonists and diuretics (0)
- C02LX: Other antihypertensives and diuretics in ATC (1)
- C02LX01: Pinacidil and diuretics
- C02N: COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02 (0)
- C03: DIURETICS (72)
- C03A: LOW-CEILING DIURETICS, THIAZIDES (22)
- C03AA: Thiazides, plain (10)
- C03AB: Thiazides and potassium in combination (9)
- C03AB01: Bendroflumethiazide and potassium
- C03AB02: Hydroflumethiazide and potassium
- C03AB03: Hydrochlorothiazide and potassium
- C03AB04: Chlorothiazide and potassium
- C03AB05: Polythiazide and potassium
- C03AB06: Trichlormethiazide and potassium
- C03AB07: Cyclopenthiazide and potassium
- C03AB08: Methyclothiazide and potassium
- C03AB09: Cyclothiazide and potassium
- C03AH: Thiazides, combinations with psycholeptics and/or analgesics (2)
- C03AX: Thiazides, combinations with other drugs (1)
- C03B: LOW-CEILING DIURETICS, EXCL. THIAZIDES (20)
- C03BA: sulfonamides, low-ceiling diuretics, plain (12)
- C03BB: Sulfonamides and potassium in combination, low-ceiling diruetics, excluding thiazides (5)
- C03BB02: Quinethazone and potassium
- C03BB03: Clopamide and potassium
- C03BB04: Chlortalidone and potassium
- C03BB05: Mefruside and potassium
- C03BB07: Clofenamide and potassium
- C03BC: Mercurial diuretics (1)
- C03BD: Xanthine derivatives, low-ceiling diuretics (1)
- C03BK: Sulfonamides, combinations with other drugs (0)
- C03BX: Other low-ceiling diuretics in ATC (1)
- C03C: HIGH-CEILING DIURETICS (10)
- C03CA: sulfonamides, high-ceiling diuretics, plain (4)
- C03CB: Sulfonamides and potassium in combination, high-ceiling diruetics, excluding thiazides (2)
- C03CB01: Furosemide and potassium
- C03CB02: Bumetanide and potassium
- C03CC: Aryloxyacetic acid derivatives, high-ceiling diuretics (2)
- C03CD: Pyrazolone derivatives, high-ceiling diuretics (1)
- C03CX: Other high-ceiling diuretics in ATC (1)
- C03D: POTASSIUM-SPARING DIURETICS (6)
- C03DA: Aldosterone antagonists (4)
- C03DB: Other potassium-sparing agents in ATC (2)
- C03E: DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION (12)
- C03EA: Low-ceiling diuretics and potassium-sparing agents (10)
- C03EA01: Hydrochlorothiazide and potassium-sparing agents
- C03EA02: Trichlormethiazide and potassium-sparing agents
- C03EA03: Epitizide and potassium-sparing agents
- C03EA04: Altizide and potassium-sparing agents
- C03EA05: Mebutizide and potassium-sparing agents
- C03EA06: Chlortalidone and potassium-sparing agents
- C03EA07: Cyclopenthiazide and potassium-sparing agents
- C03EA12: Metolazone and potassium-sparing agents
- C03EA13: Bendroflumethiazide and potassium-sparing agents
- C03EA14: Butizide and potassium-sparing agents
- C03EB: High-ceiling diuretics and potassium-sparing agents (2)
- C03EB01: Furosemide and potassium-sparing agents
- C03EB02: Bumetanide and potassium-sparing agents
- C03X: OTHER DIURETICS in ATC (2)
- C03XA: Vasopressin antagonists, diuretics (2)
- C04: PERIPHERAL VASODILATORS (35)
- C04A: PERIPHERAL VASODILATORS (35)
- C04AA: 2-amino-1-phenylethanol derivatives (3)
- C04AB: Imidazoline derivatives, peripheral vasodilators (2)
- C04AC: Nicotinic acid and derivatives, peripheral vasodilators (4)
- C04AD: Purine derivatives, peripheral vasodilators (4)
- C04AE: Ergot alkaloid peripheral vasodilators (5)
- C04AF: Enzymes, peripheral vasodilators (1)
- C04AX: Other peripheral vasodilators in ATC (16)
- C05: VASOPROTECTIVES (49)
- C05A: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE (24)
- C05AA: Corticosteroids, topical for treatment of hemorrhoids and anal fissures (9)
- C05AB: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE (0)
- C05AD: Local anesthetics for treatment of hemorrhoids and anal fissures for topical use (7)
- C05AE: Muscle relaxants FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE (3)
- C05AX: Other agents for treatment of hemorrhoids and anal fissures for topical use in ATC (5)
- C05AX01: Aluminium preparations
- C05AX02: Bismuth preparations, combinations
- C05AX03: Other preparations, combinations
- C05AX04: Zinc preparations
- C05AX05: Tribenoside
- C05B: ANTIVARICOSE THERAPY DRUGS (14)
- C05BA: Heparins or heparinoids for topical use (6)
- C05BB: Sclerosing agents for local injection (6)
- C05BX: Other sclerosing agents in ATC (2)
- C05C: CAPILLARY STABILIZING AGENTS (11)
- C05CA: Bioflavonoid drugs for capillary stabilizing (8)
- C05CX: Other capillary stabilizing agents in ATC (3)
- C07: beta-Adrenergic Blocking Agents (65)
- C07A: BETA BLOCKING AGENTS (30)
- C07AA: Beta blocking agents, non-selective (14)
- C07AB: Beta blocking agents, selective (14)
- C07AG: Alpha and beta blocking agents (2)
- C07B: BETA BLOCKING AGENTS AND THIAZIDES (14)
- C07BA: Beta blocking agents, non-selective, and thiazides (6)
- C07BA02: Oxprenolol and thiazides
- C07BA05: Propranolol and thiazides
- C07BA06: Timolol and thiazides
- C07BA07: Sotalol and thiazides
- C07BA12: Nadolol and thiazides
- C07BA68: Metipranolol and thiazides, combinations
- C07BB: Beta blocking agents, selective, and thiazides (7)
- C07BB02: Metoprolol and thiazides
- C07BB03: Atenolol and thiazides
- C07BB04: Acebutolol and thiazides
- C07BB06: Bevantolol and thiazides
- C07BB07: Bisoprolol and thiazides
- C07BB12: Nebivolol and thiazides
- C07BB52: Metoprolol and thiazides, combinations
- C07BG: Alpha and beta blocking agents and thiazides (1)
- C07BG01: Labetalol and thiazides
- C07C: BETA BLOCKING AGENTS AND OTHER DIURETICS (8)
- C07CA: Beta blocking agents, non-selective, and other diuretics (4)
- C07CA02: Oxprenolol and other diuretics
- C07CA03: Pindolol and other diuretics
- C07CA17: Bopindolol and other diuretics
- C07CA23: Penbutolol and other diuretics
- C07CB: Beta blocking agents, selective, and other diuretics (3)
- C07CB02: Metoprolol and other diuretics
- C07CB03: Atenolol and other diuretics
- C07CB53: Atenolol and other diuretics, combinations
- C07CG: Alpha and beta blocking agents and other diuretics (1)
- C07CG01: Labetalol and other diuretics
- C07D: BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS (2)
- C07DA: Beta blocking agents, non-selective, thiazides and other diuretics (1)
- C07DA06: Timolol, thiazides and other diuretics
- C07DB: Beta blocking agents, selective, thiazides and other diuretics (1)
- C07DB01: Atenolol, thiazides and other diuretics
- C07E: BETA BLOCKING AGENTS AND VASODILATORS (0)
- C07EA: Beta blocking agents, non-selective, and vasodilators (0)
- C07EB: Beta blocking agents, selective, and vasodilators (0)
- C07F: BETA BLOCKING AGENTS, OTHER COMBINATIONS (11)
- C07FB: Beta blocking agents and calcium channel blockers (5)
- C07FB02: Metoprolol and felodipine
- C07FB03: Atenolol and nifedipine
- C07FB07: Bisoprolol and amlodipine
- C07FB12: Nebivolol and amlodipine
- C07FB13: Metoprolol and amlodipine
- C07FX: Beta blocking agents, other combinations (6)
- C07FX01: Propranolol and other combinations
- C07FX02: Sotalol and acetylsalicylic acid
- C07FX03: Metoprolol and acetylsalicylic acid
- C07FX04: Bisoprolol and acetylsalicylic acid
- C07FX05: Metoprolol and ivabradine
- C07FX06: Carvedilol and ivabradine
- C08: CALCIUM CHANNEL BLOCKERS (29)
- C08C: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS (19)
- C08CA: Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects (18)
- C08CX: Other selective calcium channel blockers with mainly vascular effects in ATC (1)
- C08D: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS (4)
- C08DA: Phenylalkylamine derivatives, selective calcium channel blockers with direct cardiac effects (3)
- C08DB: Benzothiazepine derivative selective calcium channel blockers with direct cardiac effects (1)
- C08E: NON-SELECTIVE CALCIUM CHANNEL BLOCKERS (4)
- C08EA: Phenylalkylamine derivatives, non-selective calcium channel blockers (2)
- C08EX: Other non-selective calcium channel blockers in ATC (2)
- C08G: CALCIUM CHANNEL BLOCKERS AND DIURETICS (2)
- C08GA: Calcium channel blockers and diuretics (2)
- C08GA01: Nifedipine and diuretics
- C08GA02: Amlodipine and diuretics
- C09: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM (79)
- C09A: ACE INHIBITORS, PLAIN (16)
- C09AA: ACE inhibitors, plain (16)
- C09B: ACE INHIBITORS, COMBINATIONS (24)
- C09BA: ACE inhibitors and diuretics (12)
- C09BA01: Captopril and diuretics
- C09BA02: Enalapril and diuretics
- C09BA03: Lisinopril and diuretics
- C09BA04: Perindopril and diuretics
- C09BA05: Ramipril and diuretics
- C09BA06: Quinapril and diuretics
- C09BA07: Benazepril and diuretics
- C09BA08: Cilazapril and diuretics
- C09BA09: Fosinopril and diuretics
- C09BA12: Delapril and diuretics
- C09BA13: Moexipril and diuretics
- C09BA15: Zofenopril and diuretics
- C09BB: ACE inhibitors and calcium channel blockers (8)
- C09BB02: Enalapril and lercanidipine
- C09BB03: Lisinopril and amlodipine
- C09BB04: Perindopril and amlodipine
- C09BB05: Ramipril and felodipine
- C09BB06: Enalapril and nitrendipine
- C09BB07: Ramipril and amlodipine
- C09BB10: Trandolapril and verapamil
- C09BB12: Delapril and manidipine
- C09BX: ACE inhibitors, other combinations in ATC (4)
- C09BX01: Perindopril, amlodipine and indapamide
- C09BX02: Perindopril and bisoprolol
- C09BX03: Ramipril, amlodipine and hydrochlorothiazide
- C09BX04: Perindopril, bisoprolol and amlodipine
- C09C: ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN (10)
- C09CA: Angiotensin II receptor blockers (ARBs), plain (10)
- C09D: ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS (24)
- C09DA: Angiotensin II receptor blockers (ARBs) and diuretics (9)
- C09DA01: Losartan and diuretics
- C09DA02: Eprosartan and diuretics
- C09DA03: Valsartan and diuretics
- C09DA04: Irbesartan and diuretics
- C09DA06: Candesartan and diuretics
- C09DA07: Telmisartan and diuretics
- C09DA08: Olmesartan medoxomil and diuretics
- C09DA09: Azilsartan medoxomil and diuretics
- C09DA10: Fimasartan and diuretics
- C09DB: Angiotensin II receptor blockers (ARBs) and calcium channel blockers (8)
- C09DB01: Valsartan and amlodipine
- C09DB02: Olmesartan medoxomil and amlodipine
- C09DB04: Telmisartan and amlodipine
- C09DB05: Irbesartan and amlodipine
- C09DB06: Losartan and amlodipine
- C09DB07: Candesartan and amlodipine
- C09DB08: Valsartan and lercanidipine
- C09DB09: Fimasartan and amlodipine
- C09DX: Angiotensin II receptor blockers (ARBs), other combinations (7)
- C09DX01: Valsartan, amlodipine and hydrochlorothiazide
- C09DX02: Valsartan and aliskiren
- C09DX03: Olmesartan medoxomil, amlodipine and hydrochlorothiazide
- C09DX04: Valsartan and sacubitril
- C09DX05: Valsartan and nebivolol
- C09DX06: Candesartan, amlodipine and hydrochlorothiazide
- C09DX07: Irbesartan, amlodipine and hydrochlorothiazide
- C09X: OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM in ATC (5)
- C09XA: Renin-inhibitors (5)
- C10: LIPID MODIFYING AGENTS (70)
- C10A: LIPID MODIFYING AGENTS, PLAIN (44)
- C10AA: HMG CoA reductase inhibitors, plain lipid modifying drugs (8)
- C10AB: Fibrates, lipid modifying drugs, plain (11)
- C10AC: Bile acid sequestrants (4)
- C10AD: Nicotinic acid and derivatives, lipid modifying, plain (7)
- C10AX: Other lipid modifying agents in ATC (14)
- C10B: LIPID MODIFYING AGENTS, COMBINATIONS (26)
- C10BA: HMG CoA reductase inhibitors in combination with other lipid modifying agents (9)
- C10BA01: Lovastatin and nicotinic acid
- C10BA02: Simvastatin and ezetimibe
- C10BA03: Pravastatin and fenofibrate
- C10BA04: Simvastatin and fenofibrate
- C10BA05: Atorvastatin and ezetimibe
- C10BA06: Rosuvastatin and ezetimibe
- C10BA07: Rosuvastatin and omega-3 fatty acids
- C10BA08: Atorvastatin and omega-3 fatty acids
- C10BA09: Rosuvastatin and fenofibrate
- C10BX: HMG CoA reductase inhibitors, other combinations (17)
- C10BX01: Simvastatin and acetylsalicylic acid
- C10BX02: Pravastatin and acetylsalicylic acid
- C10BX03: Atorvastatin and amlodipine
- C10BX04: Simvastatin, acetylsalicylic acid and ramipril
- C10BX05: Rosuvastatin and acetylsalicylic acid
- C10BX06: Atorvastatin, acetylsalicylic acid and ramipril
- C10BX07: Rosuvastatin, amlodipine and lisinopril
- C10BX08: Atorvastatin and acetylsalicylic acid
- C10BX09: Rosuvastatin and amlodipine
- C10BX10: Rosuvastatin and valsartan
- C10BX11: Atorvastatin, amlodipine and perindopril
- C10BX12: Atorvastatin, acetylsalicylic acid and perindopril
- C10BX13: Rosuvastatin, perindopril and indapamide
- C10BX14: Rosuvastatin, amlodipine and perindopril
- C10BX15: Atorvastatin and perindopril
- C10BX16: Rosuvastatin and fimasartan
- C10BX17: Rosuvastatin and ramipril
- D: DERMATOLOGICALS (372)
- D01: ANTIFUNGALS FOR DERMATOLOGICAL USE (57)
- D01A: ANTIFUNGALS FOR TOPICAL USE (55)
- D01AA: Antifungal Antibiotics, Topical (8)
- D01AC: Imidazole and triazole derivatives, topical antifungals (22)
- D01AE: Other antifungals for topical use in ATC (25)
- D01B: ANTIFUNGALS FOR SYSTEMIC USE (2)
- D01BA: Antifungals for systemic use (2)
- D02: EMOLLIENTS AND PROTECTIVES (6)
- D02A: EMOLLIENTS AND PROTECTIVES (2)
- D02AA: Silicone emollient and protective products (0)
- D02AB: Zinc products, emollients and protectives (0)
- D02AC: Soft paraffin and fat products (0)
- D02AD: Liquid plasters (0)
- D02AE: Carbamide products, emollients and protectives (2)
- D02AF: Salicylic acid emollient and protective preparations (0)
- D02AX: Other emollients and protectives in ATC (0)
- D02B: PROTECTIVES AGAINST UV-RADIATION (4)
- D02BA: Protectives against UV-radiation for topical use (2)
- D02BB: Protectives against UV-radiation for systemic use (2)
- D03: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS (16)
- D03A: CICATRIZANTS (12)
- D03AA: Cod-liver oil ointments (0)
- D03AX: Other cicatrizants in ATC (12)
- D03B: ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS (4)
- D03BA: Proteolytic enzymes for treatment of wounds and ulcers (4)
- D04: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. (23)
- D04A: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. (23)
- D04AA: Antihistamines for topical use (15)
- D04AB: Anesthetics for topical use (7)
- D04AX: Other antipruritics in ATC (1)
- D05: ANTIPSORIATICS (16)
- D05A: ANTIPSORIATICS FOR TOPICAL USE (10)
- D05AA: Tars, topical antipsoriatics (0)
- D05AC: Antracen derivatives, topical antipsoriatics (2)
- D05AD: Psoralens for topical use (2)
- D05AX: Other antipsoriatics for topical use in ATC (6)
- D05B: ANTIPSORIATICS FOR SYSTEMIC USE (6)
- D05BA: Psoralens for systemic use (3)
- D05BB: Retinoids for treatment of psoriasis (2)
- D05BX: Other antipsoriatics for systemic use in ATC (1)
- D05BX51: Fumaric acid derivatives, combinations
- D06: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE (39)
- D06A: ANTIBIOTICS FOR TOPICAL USE (17)
- D06AA: Tetracycline and derivatives, topical antibiotics (4)
- D06AX: Other antibiotics for topical use in ATC (13)
- D06B: CHEMOTHERAPEUTICS FOR TOPICAL USE (22)
- D06BA: Sulfonamides, topical (7)
- D06BB: Antivirals, topical (13)
- D06BX: Other chemotherapeutics in ATC (2)
- D06C: ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS (0)
- D07: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS (77)
- D07A: CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN (39)
- D07AA: Corticosteroids, weak (group I) (3)
- D07AB: Corticosteroids, moderately potent (group II) (14)
- D07AC: Corticosteroids, potent (group III) (20)
- D07AD: Corticosteroids, very potent (group IV) (2)
- D07B: CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS (10)
- D07BA: Corticosteroids, weak, combinations with antiseptics (2)
- D07BA01: Prednisolone and antiseptics
- D07BA04: Hydrocortisone and antiseptics
- D07BB: Corticosteroids, moderately potent, combinations with antiseptics (4)
- D07BB01: Flumetasone and antiseptics
- D07BB02: Desonide and antiseptics
- D07BB03: Triamcinolone and antiseptics
- D07BB04: Hydrocortisone butyrate and antiseptics
- D07BC: Corticosteroids, potent, combinations with antiseptics (4)
- D07BC01: Betamethasone and antiseptics
- D07BC02: Fluocinolone acetonide and antiseptics
- D07BC03: Fluocortolone and antiseptics
- D07BC04: Diflucortolone and antiseptics
- D07BD: Corticosteroids, very potent, combinations with antiseptics (0)
- D07C: CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS (15)
- D07CA: Corticosteroids, weak, combinations with antibiotics (3)
- D07CA01: Hydrocortisone and antibiotics
- D07CA02: Methylprednisolone and antibiotics
- D07CA03: Prednisolone and antibiotics
- D07CB: Corticosteroids, moderately potent, combinations with antibiotics (5)
- D07CB01: Triamcinolone and antibiotics
- D07CB02: Fluprednidene and antibiotics
- D07CB03: Fluorometholone and antibiotics
- D07CB04: Dexamethasone and antibiotics
- D07CB05: Flumetasone and antibiotics
- D07CC: Corticosteroids, potent, combinations with antibiotics (6)
- D07CC01: Betamethasone and antibiotics
- D07CC02: Fluocinolone acetonide and antibiotics
- D07CC03: Fludroxycortide and antibiotics
- D07CC04: Beclometasone and antibiotics
- D07CC05: Fluocinonide and antibiotics
- D07CC06: Fluocortolone and antibiotics
- D07CD: Corticosteroids, very potent, combinations with antibiotics (1)
- D07CD01: Clobetasol and antibiotics
- D07X: CORTICOSTEROIDS, OTHER COMBINATIONS (13)
- D07XA: Corticosteroids, weak, other combinations (2)
- D07XB: Corticosteroids, moderately potent, other combinations (6)
- D07XC: Corticosteroids, potent, other combinations (5)
- D07XD: Corticosteroids, very potent, other combinations (0)
- D08: ANTISEPTICS AND DISINFECTANTS (53)
- D08A: ANTISEPTICS AND DISINFECTANTS (53)
- D08AA: Acridine derivatives, antiseptics and disinfectants (3)
- D08AB: Aluminium agents, antiseptics and disinfectants (0)
- D08AC: Biguanides and amidines as antiseptics and disinfectants (6)
- D08AD: Boric acid antiseptics and disinfectants (0)
- D08AE: Phenol and derivatives, antiseptics and disinfectants (6)
- D08AF: Nitrofuran derivatives, antiseptics and disinfectants (1)
- D08AG: Iodine products, antiseptics and disinfectants (4)
- D08AH: Quinoline derivatives, antiseptics and disinfectants (4)
- D08AJ: Quaternary ammonium compounds, antiseptics and disinfectants (11)
- D08AK: Mercurial antiseptic and disinfectant products (7)
- D08AL: Silver compounds, antiseptics and disinfectants (2)
- D08AX: Other antiseptics and disinfectants in ATC (9)
- D09: MEDICATED DRESSINGS (15)
- D09A: MEDICATED DRESSINGS (15)
- D09AA: Medicated dressings with antiinfectives (13)
- D09AB: Zinc bandages (2)
- D09AB01: Zinc bandage without supplements
- D09AB02: Zinc bandage with supplements
- D09AX: Soft paraffin dressings (0)
- D10: ANTI-ACNE PREPARATIONS (34)
- D10A: ANTI-ACNE PREPARATIONS FOR TOPICAL USE (32)
- D10AA: Corticosteroids, combinations for treatment of acne (3)
- D10AB: Preparations containing sulfur, anti-acne preparations for topical use (4)
- D10AD: Retinoids for topical use in acne (9)
- D10AE: Peroxide anti-acne preparations for topical use (2)
- D10AF: Antiinfectives for treatment of acne (8)
- D10AX: Other anti-acne preparations for topical use in ATC (6)
- D10B: ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE (2)
- D10BA: Retinoids for treatment of acne (1)
- D10BX: Other anti-acne preparations for systemic use in ATC (1)
- D11: OTHER DERMATOLOGICAL PREPARATIONS in ATC (36)
- D11A: OTHER DERMATOLOGICAL PREPARATIONS in ATC (36)
- D11AA: Antihidrotics (1)
- D11AC: Medicated shampoos (7)
- D11AE: Androgens for topical use (1)
- D11AF: Wart and anti-corn preparations (0)
- D11AH: Agents for dermatitis, excluding corticosteroids (6)
- D11AX: OTHER DERMATOLOGICAL PREPARATIONS IN ATC (21)
- G: GENITO URINARY SYSTEM AND SEX HORMONES (280)
- G01: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS (57)
- G01A: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS (57)
- G01AA: Antibiotics, Gynecological (12)
- G01AB: Arsenic compounds, Gynecological (1)
- G01AC: Quinoline gynecological antiinfectives (6)
- G01AD: Organic acids, Gynecological (3)
- G01AE: Sulfonamides, Gynecological (2)
- G01AF: Imidazole derivatives, gyncological antiinfectives (18)
- G01AG: Triazole derivatives, gynecological antiinfectives and antiseptics (1)
- G01AX: Other gynecological antiinfectives and antiseptics in ATC (14)
- G01B: ANTIINFECTIVES/ANTISEPTICS IN COMBINATION WITH CORTICOSTEROIDS (0)
- G01BA: Antibiotics and corticosteroids (0)
- G01BC: Quinoline derivative antiinfectives/antiseptics and corticosteroids (0)
- G01BD: Antiseptics and corticosteroids (0)
- G01BE: Sulfonamides antiinfectives/antiseptics and corticosteroids (0)
- G01BF: Imidazole derivatives antiinfectives/antiseptics and corticosteroids (0)
- G02: OTHER GYNECOLOGICALS in ATC (32)
- G02A: UTEROTONICS (10)
- G02AB: Ergot alkaloid oxytocics (3)
- G02AC: Ergot alkaloids and oxytocin incl. analogues, in combination (1)
- G02AC01: Methylergometrine and oxytocin
- G02AD: Prostaglandins, oxytocics (6)
- G02AX: Other uterotonics in ATC (0)
- G02B: CONTRACEPTIVES FOR TOPICAL USE (5)
- G02BA: Intrauterine contraceptives (3)
- G02BA01: Plastic IUD
- G02BA02: Plastic IUD with copper
- G02BA03: Plastic IUD with progestogen
- G02BB: Intravaginal contraceptives (2)
- G02BB01: Vaginal ring with progestogen and estrogen
- G02BB02: Vaginal ring with progestogen
- G02C: OTHER GYNECOLOGICALS in ATC (17)
- G02CA: Sympathomimetics, labour repressants (3)
- G02CB: Prolactine inhibitors (6)
- G02CC: Antiinflammatory products for vaginal administration (4)
- G02CX: Other gynecologicals in ATC (4)
- G03: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM (140)
- G03A: HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE (38)
- G03AA: Progestogens and estrogen systemic contraceptives, fixed combinations (17)
- G03AA01: Etynodiol and ethinylestradiol
- G03AA02: Quingestanol and ethinylestradiol
- G03AA03: Lynestrenol and ethinylestradiol
- G03AA04: Megestrol and ethinylestradiol
- G03AA05: Norethisterone and ethinylestradiol
- G03AA06: Norgestrel and ethinylestradiol
- G03AA07: Levonorgestrel and ethinylestradiol
- G03AA08: Medroxyprogesterone and ethinylestradiol
- G03AA09: Desogestrel and ethinylestradiol
- G03AA10: Gestodene and ethinylestradiol
- G03AA11: Norgestimate and ethinylestradiol
- G03AA12: Drospirenone and ethinylestradiol
- G03AA13: Norelgestromin and ethinylestradiol
- G03AA14: Nomegestrol and estradiol
- G03AA15: Chlormadinone and ethinylestradiol
- G03AA16: Dienogest and ethinylestradiol
- G03AA17: Medroxyprogesterone and estradiol
- G03AB: Progestogens and estrogens systemic contraceptives, sequential preparations (9)
- G03AB01: Megestrol and ethinylestradiol
- G03AB02: Lynestrenol and ethinylestradiol
- G03AB03: Levonorgestrel and ethinylestradiol
- G03AB04: Norethisterone and ethinylestradiol
- G03AB05: Desogestrel and ethinylestradiol
- G03AB06: Gestodene and ethinylestradiol
- G03AB07: Chlormadinone and ethinylestradiol
- G03AB08: Dienogest and estradiol
- G03AB09: Norgestimate and ethinylestradiol
- G03AC: Progestogen systemic hormonal contraceptives (10)
- G03AD: Emergency contraceptive drugs (2)
- G03B: ANDROGENS (5)
- G03BA: 3-oxoandrosten (4) derivatives (3)
- G03BB: 5-androstanon (3) derivatives (2)
- G03C: ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM (19)
- G03CA: Natural and semisynthetic estrogens, plain (8)
- G03CB: Synthetic estrogens, plain (4)
- G03CC: Estrogens, combinations with other drugs (6)
- G03CX: Other estrogens in ATC (1)
- G03D: PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM (18)
- G03DA: Pregnen (4) derivatives, progestogens (4)
- G03DB: Pregnadien derivatives, progestogens (8)
- G03DC: Estren derivatives, sex hormones and modulators of the genital system (6)
- G03E: ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION (4)
- G03EA: Androgens and estrogens (3)
- G03EA01: Methyltestosterone and estrogen
- G03EA02: Testosterone and estrogen
- G03EA03: Prasterone and estrogen
- G03EB: Androgen, progestogen and estrogen in combination (0)
- G03EK: Androgens and female sex hormones in combination with other drugs (1)
- G03F: PROGESTOGENS AND ESTROGENS IN COMBINATION (29)
- G03FA: Progestogens and estrogens, fixed combinations (17)
- G03FA01: Norethisterone and estrogen
- G03FA02: Hydroxyprogesterone and estrogen
- G03FA03: Ethisterone and estrogen
- G03FA04: Progesterone and estrogen
- G03FA05: Methylnortestosterone and estrogen
- G03FA06: Etynodiol and estrogen
- G03FA07: Lynestrenol and estrogen
- G03FA08: Megestrol and estrogen
- G03FA09: Noretynodrel and estrogen
- G03FA10: Norgestrel and estrogen
- G03FA11: Levonorgestrel and estrogen
- G03FA12: Medroxyprogesterone and estrogen
- G03FA13: Norgestimate and estrogen
- G03FA14: Dydrogesterone and estrogen
- G03FA15: Dienogest and estrogen
- G03FA16: Trimegestone and estrogen
- G03FA17: Drospirenone and estrogen
- G03FB: Progestogens and estrogens, sequential preparations (12)
- G03FB01: Norgestrel and estrogen
- G03FB02: Lynestrenol and estrogen
- G03FB03: Chlormadinone and estrogen
- G03FB04: Megestrol and estrogen
- G03FB05: Norethisterone and estrogen
- G03FB06: Medroxyprogesterone and estrogen
- G03FB07: Medrogestone and estrogen
- G03FB08: Dydrogesterone and estrogen
- G03FB09: Levonorgestrel and estrogen
- G03FB10: Desogestrel and estrogen
- G03FB11: Trimegestone and estrogen
- G03FB12: Nomegestrol and estrogen
- G03G: GONADOTROPINS AND OTHER OVULATION STIMULANTS (14)
- G03GA: Gonadotropins (11)
- G03GB: Ovulation stimulants, synthetic (3)
- G03H: ANTIANDROGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM (2)
- G03HA: Antiandrogens, plain (1)
- G03HB: Antiandrogens and estrogens (1)
- G03HB01: Cyproterone and estrogen
- G03X: OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC (11)
- G03XA: Antigonadotropins and similar agents (2)
- G03XB: Progesterone receptor modulators, sex hormones and modulators of the genital system (3)
- G03XC: Selective estrogen receptor modulators (5)
- G03XX: Other sex hormones and modulators of the genital system in ATC (1)
- G04: UROLOGICALS (51)
- G04B: UROLOGICALS (37)
- G04BA: Acidifiers (2)
- G04BC: Urinary concrement solvents (0)
- G04BD: Drugs for urinary frequency and incontinence (13)
- G04BE: Drugs used in erectile dysfunction (12)
- G04BX: Other urologicals in ATC (10)
- G04C: DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY (14)
- G04CA: Alpha-adrenoreceptor antagonists, benign prostatic hypertrophy (8)
- G04CB: Testosterone-5-alpha reductase inhibitors for benign prostatic hypertrophy (2)
- G04CX: Other drugs used in benign prostatic hypertrophy in ATC (4)
- H: SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS (76)
- H01: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES (28)
- H01A: ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES (10)
- H01AA: ACTH and synthetic analog preparations (2)
- H01AB: Thyrotropin Class in ATC (1)
- H01AC: Somatropin and somatropin agonists (6)
- H01AX: Other anterior pituitary lobe hormones and analogues in ATC (1)
- H01B: POSTERIOR PITUITARY LOBE HORMONES (8)
- H01BA: Vasopressin and analogues (5)
- H01BB: Oxytocin and analogues (3)
- H01C: HYPOTHALAMIC HORMONES (10)
- H01CA: Gonadotropin-releasing hormones (2)
- H01CB: Somatostatin and analogues (5)
- H01CC: Anti-gonadotropin-releasing hormones (3)
- H02: CORTICOSTEROIDS FOR SYSTEMIC USE (22)
- H02A: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN (19)
- H02AA: Mineralocorticoids for systemic use, plain (3)
- H02AB: Glucocorticoids, Systemic (16)
- H02B: CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS (1)
- H02BX: Corticosteroids for systemic use, combinations (1)
- H02C: ANTIADRENAL PREPARATIONS (2)
- H02CA: Anticorticosteroids (2)
- H03: THYROID THERAPY DRUGS (14)
- H03A: THYROID PREPARATIONS (5)
- H03AA: Thyroid hormones (5)
- H03B: ANTITHYROID PREPARATIONS (9)
- H03BA: Thiouracil antithyroid preparations (3)
- H03BB: Sulfur-containing imidazole derivatives, antithyroid preparations (3)
- H03BC: Perchlorate antithyroid preparations (1)
- H03BX: Other antithyroid preparations in ATC (2)
- H03C: IODINE THERAPY DRUGS (0)
- H03CA: Iodine therapy (0)
- H04: PANCREATIC HORMONES (1)
- H04A: GLYCOGENOLYTIC HORMONES (1)
- H04AA: Glycogenolytic hormones (1)
- H05: CALCIUM HOMEOSTASIS (11)
- H05A: PARATHYROID HORMONES AND ANALOGUES (3)
- H05AA: Parathyroid hormones and analogues (3)
- H05B: ANTI-PARATHYROID AGENTS (8)
- H05BA: Calcitonin preparations (4)
- H05BX: Other anti-parathyroid agents in ATC (4)
- J: ANTIINFECTIVES FOR SYSTEMIC USE (542)
- J01: ANTIBACTERIALS FOR SYSTEMIC USE (270)
- J01A: Tetracycline antibiotics (17)
- J01AA: Tetracyclines (17)
- J01B: AMPHENICOLS (3)
- J01BA: Amphenicol antibacterials, systemic (3)
- J01C: BETA-LACTAM ANTIBACTERIALS, PENICILLINS (46)
- J01CA: Penicillins with extended spectrum (21)
- J01CE: Beta-lactamase sensitive penicillins (11)
- J01CF: Beta-lactamase resistant penicillins (6)
- J01CG: Beta-lactamase inhibitors, systemic penicillins (2)
- J01CR: Combinations of penicillins, incl. beta-lactamase inhibitors (6)
- J01CR01: Ampicillin and beta-lactamase inhibitor
- J01CR02: Amoxicillin and beta-lactamase inhibitor
- J01CR03: Ticarcillin and beta-lactamase inhibitor
- J01CR04: Sultamicillin
- J01CR05: Piperacillin and beta-lactamase inhibitor
- J01CR50: Combinations of penicillins
- J01D: OTHER BETA-LACTAM ANTIBACTERIALS in ATC (67)
- J01DB: First-generation cephalosporins (12)
- J01DC: Second-generation cephalosporins (14)
- J01DD: Third-generation cephalosporins (24)
- J01DE: Fourth-generation cephalosporins (3)
- J01DF: Monobactams (2)
- J01DH: Carbapenems (8)
- J01DI: Other cephalosporins and penems in ATC (4)
- J01E: SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE (33)
- J01EA: Trimethoprim and derivatives, systemic antibacterials (3)
- J01EB: Short-acting sulfonamides (9)
- J01EC: Intermediate-acting sulfonamides (4)
- J01ED: Long-acting sulfonamides (10)
- J01EE: Combinations of sulfonamides and trimethoprim, incl. derivatives (7)
- J01EE01: Sulfamethoxazole and trimethoprim
- J01EE02: Sulfadiazine and trimethoprim
- J01EE03: Sulfametrole and trimethoprim
- J01EE04: Sulfamoxole and trimethoprim
- J01EE05: Sulfadimidine and trimethoprim
- J01EE06: Sulfadiazine and tetroxoprim
- J01EE07: Sulfamerazine and trimethoprim
- J01F: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS (19)
- J01FA: Macrolides (15)
- J01FF: Lincosamides (2)
- J01FG: Streptogramins (2)
- J01G: AMINOGLYCOSIDE ANTIBACTERIALS (15)
- J01GA: Streptomycins (2)
- J01GB: Other aminoglycosides in ATC (13)
- J01M: QUINOLONE ANTIBACTERIALS (30)
- J01MA: Fluoroquinolone antibacterials, systemic (22)
- J01MB: Other quinolones in ATC (8)
- J01R: COMBINATIONS OF ANTIBACTERIALS (13)
- J01RA: Combinations of antibacterials (13)
- J01RA01: Penicillins, combinations with other antibacterials
- J01RA02: Sulfonamides, combinations with other antibacterials (excl. trimethoprim)
- J01RA03: Cefuroxime and metronidazole
- J01RA04: Spiramycin and metronidazole
- J01RA05: Levofloxacin and ornidazole
- J01RA06: Cefepime and amikacin
- J01RA07: Azithromycin, fluconazole and secnidazole
- J01RA08: Tetracycline and oleandomycin
- J01RA09: Ofloxacin and ornidazole
- J01RA10: Ciprofloxacin and metronidazole
- J01RA11: Ciprofloxacin and tinidazole
- J01RA12: Ciprofloxacin and ornidazole
- J01RA13: Norfloxacin and tinidazole
- J01X: OTHER ANTIBACTERIALS in ATC (27)
- J01XA: Glycopeptide antibacterials (5)
- J01XB: Polymyxins (2)
- J01XC: Steroid antibacterials (1)
- J01XD: Imidazole derivatives, antibacterial for systemic use (3)
- J01XE: Nitrofuran derivatives, antibacterials for systemic use (4)
- J01XX: Other antibacterials in ATC (12)
- J02: ANTIMYCOTICS FOR SYSTEMIC USE (13)
- J02A: ANTIMYCOTICS FOR SYSTEMIC USE (13)
- J02AA: Antibiotics for systemic use (2)
- J02AB: Imidazole derivatives, antimycotic for systemic use (2)
- J02AC: Triazole derivatives, systemic antimycotics (5)
- J02AX: Other antimycotics for systemic use in ATC (4)
- J04: ANTIMYCOBACTERIALS (33)
- J04A: DRUGS FOR TREATMENT OF TUBERCULOSIS (30)
- J04AA: Aminosalicylic acid and derivatives (3)
- J04AB: Antibiotics, Antitubercular (7)
- J04AC: Hydrazides for tuberculosis treatment (2)
- J04AD: Thiocarbamide derivatives for treatment of tuberculosis (3)
- J04AK: Other drugs for treatment of tuberculosis in ATC (7)
- J04AM: Combinations of drugs for treatment of tuberculosis (8)
- J04AM01: Streptomycin and isoniazid
- J04AM02: Rifampicin and isoniazid
- J04AM03: Ethambutol and isoniazid
- J04AM04: Thioacetazone and isoniazid
- J04AM05: Rifampicin, pyrazinamide and isoniazid
- J04AM06: Rifampicin, pyrazinamide, ethambutol and isoniazid
- J04AM07: Rifampicin, ethambutol and isoniazid
- J04AM08: Isoniazid, sulfamethoxazole, trimethoprim and pyridoxine
- J04B: DRUGS FOR TREATMENT OF LEPRA (3)
- J04BA: Drugs for treatment of lepra (3)
- J05: ANTIVIRALS FOR SYSTEMIC USE (113)
- J05A: DIRECT ACTING ANTIVIRALS (113)
- J05AA: Thiosemicarbazones, direct acting antivirals (1)
- J05AB: Nucleosides and nucleotides excl. reverse transcriptase inhibitors (10)
- J05AC: Cyclic amines, direct acting antivirals (2)
- J05AD: Phosphonic acid derivatives, direct acting antivirals (2)
- J05AE: Protease inhibitors, direct acting antivirals (9)
- J05AF: Nucleoside and nucleotide reverse transcriptase inhibitors (13)
- J05AG: Non-nucleoside reverse transcriptase inhibitors (6)
- J05AH: Neuraminidase inhibitors, direct acting antivirals (4)
- J05AP: Antivirals for treatment of HCV infections (19)
- J05AR: Antivirals for treatment of HIV infections, combinations (27)
- J05AR01: Zidovudine and lamivudine
- J05AR02: Lamivudine and abacavir
- J05AR03: Tenofovir disoproxil and emtricitabine
- J05AR04: Zidovudine, lamivudine and abacavir
- J05AR05: Zidovudine, lamivudine and nevirapine
- J05AR06: Emtricitabine, tenofovir disoproxil and efavirenz
- J05AR07: Stavudine, lamivudine and nevirapine
- J05AR08: Emtricitabine, tenofovir disoproxil and rilpivirine
- J05AR09: Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
- J05AR10: Lopinavir and ritonavir
- J05AR11: Lamivudine, tenofovir disoproxil and efavirenz
- J05AR12: Lamivudine and tenofovir disoproxil
- J05AR13: Lamivudine, abacavir and dolutegravir
- J05AR14: Darunavir and cobicistat
- J05AR15: Atazanavir and cobicistat
- J05AR16: Lamivudine and raltegravir
- J05AR17: Emtricitabine and tenofovir alafenamide
- J05AR18: Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
- J05AR19: Emtricitabine, tenofovir alafenamide and rilpivirine
- J05AR20: Emtricitabine, tenofovir alafenamide and bictegravir
- J05AR21: Dolutegravir and rilpivirine
- J05AR22: Emtricitabine, tenofovir alafenamide, darunavir and cobicistat
- J05AR23: Atazanavir and ritonavir
- J05AR24: Lamivudine, tenofovir disoproxil and doravirine
- J05AR25: Lamivudine and dolutegravir
- J05AR26: Darunavir and ritonavir
- J05AR27: Lamivudine, tenofovir disoproxil and dolutegravir
- J05AX: Other antivirals in ATC (20)
- J06: IMMUNE SERA AND IMMUNOGLOBULINS (31)
- J06A: IMMUNE SERA SYSTEMIC ANTIINFECTIVES (6)
- J06B: IMMUNOGLOBULINS (25)
- J06BA: Immunoglobulins, normal human (2)
- J06BA01: Immunoglobulins, normal human, for extravascular adm.
- J06BA02: Immunoglobulins, normal human, for intravascular adm.
- J06BB: Specific immunoglobulins (22)
- J06BC: Other immunoglobulins in ATC (1)
- J07: VACCINES (82)
- J07A: BACTERIAL VACCINES (37)
- J07AC: Anthrax vaccines (1)
- J07AD: Brucellosis vaccines (1)
- J07AD01: Brucella antigen
- J07AE: Cholera vaccines (3)
- J07AF: Diphtheria vaccines (1)
- J07AG: Haemophilus influenzae B vaccines (4)
- J07AG01: Haemophilus influenzae B, purified antigen conjugated
- J07AG51: Haemophilus influenzae B, combinations with toxoids
- J07AG52: Haemophilus influenzae B, combinations with pertussis and toxoids
- J07AG53: Haemophilus influenzae B, combinations with meningococcus C, conjugated
- J07AH: Meningococcal vaccines (10)
- J07AH01: Meningococcus A, purified polysaccharides antigen
- J07AH02: Other meningococcal monovalent purified polysaccharides antigen
- J07AH03: Meningococcus A,C, bivalent purified polysaccharides antigen
- J07AH04: Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen
- J07AH05: Other meningococcal polyvalent purified polysaccharides antigen
- J07AH06: Meningococcus B, outer membrane vesicle vaccine
- J07AH07: Meningococcus C, purified polysaccharides antigen conjugated
- J07AH08: Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
- J07AH09: Meningococcus B, multicomponent vaccine
- J07AH10: Meningococcus A, purified polysaccharides antigen conjugated
- J07AJ: Pertussis vaccines (4)
- J07AK: Plague vaccines (1)
- J07AK01: Plague, inactivated, whole cell
- J07AL: Pneumococcal vaccines (3)
- J07AL01: Pneumococcus, purified polysaccharides antigen
- J07AL02: Pneumococcus, purified polysaccharides antigen conjugated
- J07AL52: Pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated
- J07AM: Tetanus vaccines (3)
- J07AN: Tuberculosis vaccines (1)
- J07AN01: Tuberculosis, live attenuated
- J07AP: Typhoid vaccines (4)
- J07AP01: Typhoid, oral, live attenuated
- J07AP02: Typhoid, inactivated, whole cell
- J07AP03: Typhoid, purified polysaccharide antigen
- J07AP10: Typhoid, combinations with paratyphi types
- J07AR: Typhus (exanthematicus) vaccines (1)
- J07AR01: Typhus exanthematicus, inactivated, whole cell
- J07AX: Other bacterial vaccines in ATC (0)
- J07B: VIRAL VACCINES (32)
- J07BA: Encephalitis vaccines (3)
- J07BA01: Encephalitis, tick borne, inactivated, whole virus
- J07BA02: Encephalitis, Japanese, inactivated, whole virus
- J07BA03: Encephalitis, Japanese, live attenuated
- J07BB: Influenza vaccines (3)
- J07BC: Hepatitis vaccines (3)
- J07BC01: Hepatitis B, purified antigen
- J07BC02: Hepatitis A, inactivated, whole virus
- J07BC20: Hepatitis vaccine combinations
- J07BD: Measles vaccines (5)
- J07BD01: Measles, live attenuated
- J07BD51: Measles, combinations with mumps, live attenuated
- J07BD52: Measles, combinations with mumps and rubella, live attenuated
- J07BD53: Measles, combinations with rubella, live attenuated
- J07BD54: Measles, combinations with mumps, rubella and varicella, live attenuated
- J07BE: Mumps vaccines (1)
- J07BF: Poliomyelitis vaccines (4)
- J07BF01: Poliomyelitis oral, monovalent, live attenuated
- J07BF02: Poliomyelitis oral, trivalent, live attenuated
- J07BF03: Poliomyelitis, trivalent, inactivated, whole virus
- J07BF04: Poliomyelitis oral, bivalent, live attenuated
- J07BG: Rabies vaccines (1)
- J07BG01: Rabies, inactivated, whole virus
- J07BH: Rota virus diarrhea vaccines (2)
- J07BH01: Rota virus, live attenuated
- J07BH02: Rota virus, pentavalent, live, reassorted
- J07BJ: Rubella vaccines (2)
- J07BJ01: Rubella, live attenuated
- J07BJ51: Rubella, combinations with mumps, live attenuated
- J07BK: Varicella zoster vaccines (3)
- J07BK01: Varicella, live attenuated
- J07BK02: Zoster, live attenuated
- J07BK03: Zoster, purified antigen
- J07BL: Yellow fever vaccines (1)
- J07BM: Papillomavirus vaccines (3)
- J07BM01: Papillomavirus (human types 6, 11, 16, 18)
- J07BM02: Papillomavirus (human types 16, 18)
- J07BM03: Papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)
- J07BX: Other viral vaccines in ATC (1)
- J07BX01: Smallpox, live attenuated
- J07C: BACTERIAL AND VIRAL VACCINES, COMBINED (13)
- J07CA: Bacterial and viral vaccines, combined (13)
- J07CA01: Diphtheria-poliomyelitis-tetanus
- J07CA02: Diphtheria-pertussis-poliomyelitis-tetanus
- J07CA03: Diphtheria-rubella-tetanus
- J07CA04: Haemophilus influenzae B and poliomyelitis
- J07CA05: Diphtheria-hepatitis B-pertussis-tetanus
- J07CA06: Diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus
- J07CA07: Diphtheria-hepatitis B-tetanus
- J07CA08: Haemophilus influenzae B and hepatitis B
- J07CA09: Diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B
- J07CA10: Typhoid-hepatitis A
- J07CA11: Diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B
- J07CA12: Diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B
- J07CA13: Diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C
- J07X: OTHER VACCINES in ATC (0)
- L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS (376)
- L01: ANTINEOPLASTIC AGENTS (230)
- L01A: ALKYLATING AGENTS (27)
- L01AA: Nitrogen mustard analogues (8)
- L01AB: Alkyl sulfonate alkylating agents (3)
- L01AC: Ethylene imines, antineoplastic alkylating drugs (3)
- L01AD: Nitrosoureas, antineoplastic alkylating agents (8)
- L01AG: Epoxides, antineoplastic alkylating drugs (1)
- L01AX: Other alkylating agents in ATC (4)
- L01B: ANTIMETABOLITES (22)
- L01BA: Folic acid analogs, antimetabolites (4)
- L01BB: Purine analogs, antimetabolites antineoplastic (6)
- L01BC: Pyrimidine analogues, antineoplastic antimetabolites (12)
- L01C: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, ANTINEOPLASTIC DRUGS (14)
- L01CA: Vinca alkaloids and analogues, antineoplastic (6)
- L01CB: Podophyllotoxin derivatives, antineoplastic drugs (2)
- L01CC: Colchicine derivatives, antineooplastic (1)
- L01CD: Taxanes, antineoplastic (4)
- L01CX: Other plant alkaloids and natural products in ATC (1)
- L01D: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES (16)
- L01DA: Actinomycines (1)
- L01DB: Anthracyclines and related substances (11)
- L01DC: Other cytotoxic antibiotics in ATC (4)
- L01X: OTHER ANTINEOPLASTIC AGENTS in ATC (151)
- L01XA: Platinum compounds, antineoplastic drugs (5)
- L01XB: Methylhydrazines, antineoplastics (1)
- L01XC: Monoclonal antibodies, antineoplastic (30)
- L01XD: Sensitizers used in photodynamic/radiation therapy (6)
- L01XE: Protein kinase inhibitors, antineoplastic drugs (53)
- L01XX: Other antineoplastic agents in ATC (55)
- L01XY: Combinations of antineoplastic agents (1)
- L01XY01: Cytarabine and daunorubicin
- L02: ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS (31)
- L02A: HORMONES AND RELATED AGENTS (13)
- L02AA: Estrogens, endocrine therapy drugs (4)
- L02AB: Progestogens, endocrine therapy drugs (3)
- L02AE: Gonadotropin releasing hormone analogues, endocrine therapy drugs (6)
- L02AX: Other hormones for endocrine therapy in ATC (0)
- L02B: HORMONE ANTAGONISTS AND RELATED AGENTS (18)
- L02BA: Anti-estrogens (3)
- L02BB: Anti-androgen hormone antagonists and related agents (6)
- L02BG: Aromatase inhibitors (6)
- L02BX: Other hormone antagonists and related agents in ATC (3)
- L03: IMMUNOSTIMULANTS (48)
- L03A: IMMUNOSTIMULANTS (48)
- L03AA: Colony stimulating factors (10)
- L03AB: Interferons (17)
- L03AC: Interleukins (2)
- L03AX: Other immunostimulants in ATC (19)
- L04: IMMUNOSUPPRESSANTS (67)
- L04A: IMMUNOSUPPRESSANTS (67)
- L04AA: Selective immunosuppressants (32)
- L04AB: Tumor necrosis factor alpha (TNF-a) inhibitors (7)
- L04AC: Interleukin inhibitors (17)
- L04AD: Calcineurin inhibitors (3)
- L04AX: Other immunosuppressants in ATC (8)
- M: MUSCULO-SKELETAL SYSTEM DRUGS (224)
- M01: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS (91)
- M01A: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS (80)
- M01AA: Butylpyrazolidines, antiinflammatory and antirheumatic drugs (5)
- M01AB: Acetic acid derivatives and related substances (19)
- M01AC: Oxicams, antiinflammatory and antirheumatic drugs (6)
- M01AE: Propionic acid derivatives, antiinflammatory and antirheumatic products (22)
- M01AG: Fenamates, antiinflammatory and antirheumatic drugs (4)
- M01AH: Coxibs (7)
- M01AX: Other antiinflammatory and antirheumatic agents, non-steroids in ATC (17)
- M01B: ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION (3)
- M01BA: Antiinflammatory/antirheumatic agents in combination with corticosteroids (3)
- M01BA01: Phenylbutazone and corticosteroids
- M01BA02: Dipyrocetyl and corticosteroids
- M01BA03: Acetylsalicylic acid and corticosteroids
- M01BX: Other antiinflammatory/antirheumatic agents in combination with other drugs in ATC (0)
- M01C: SPECIFIC ANTIRHEUMATIC AGENTS (8)
- M01CA: Quinolines, antirheumatic drugs (1)
- M01CB: Gold preparations (5)
- M01CC: Penicillamine and similar antirheumatic agents (2)
- M01CX: Other specific antirheumatic agents in ATC (0)
- M02: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN (34)
- M02A: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN (34)
- M02AA: Antiinflammatory preparations, non-steroids for topical use (27)
- M02AB: Capsaicin and similar agents (2)
- M02AC: Preparations with salicylic acid derivatives, topical for joint and muscle pain (0)
- M02AX: Other topical products for joint and muscular pain in ATC (5)
- M03: MUSCLE RELAXANTS (47)
- M03A: MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS (16)
- M03AA: Curare alkaloid muscle relaxants, peripherally acting (3)
- M03AB: Choline derivative muscle relaxants, peripherally acting (1)
- M03AC: Other quaternary ammonium compounds in ATC, muscle relaxants, peripherally acting (11)
- M03AX: Other peripherally acting muscle relaxants in ATC (1)
- M03B: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS (30)
- M03BA: Carbamic acid esters, centrally acting muscle relaxants (11)
- M03BB: Oxazol, thiazine, and triazine derivatives centrally acting muscle relaxants (6)
- M03BC: Ethers chemically close to antihistamines, centrally acting muscle relaxants (2)
- M03BX: Other centrally acting agents in ATC (11)
- M03C: MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS (1)
- M03CA: Dantrolene and derivatives, muscle relaxants, direct acting (1)
- M04: ANTIGOUT PREPARATIONS (13)
- M04A: ANTIGOUT PREPARATIONS (13)
- M04AA: Preparations inhibiting uric acid production (4)
- M04AB: Preparations increasing uric acid excretion (5)
- M04AC: Preparations with no effect on uric acid metabolism (2)
- M04AX: Other antigout preparations in ATC (2)
- M05: DRUGS FOR TREATMENT OF BONE DISEASES (26)
- M05B: DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION (26)
- M05BA: Bisphosphonate drugs affecting bone structure and mineralization (8)
- M05BB: Bisphosphonates, combinations affecting bone structure and mineralization (9)
- M05BB01: Etidronic acid and calcium, sequential
- M05BB02: Risedronic acid and calcium, sequential
- M05BB03: Alendronic acid and colecalciferol
- M05BB04: Risedronic acid, calcium and colecalciferol, sequential
- M05BB05: Alendronic acid, calcium and colecalciferol, sequential
- M05BB06: Alendronic acid and alfacalcidol, sequential
- M05BB07: Risedronic acid and colecalciferol
- M05BB08: Zoledronic acid, calcium and colecalciferol, sequential
- M05BB09: Ibandronic acid and colecalciferol
- M05BC: Bone morphogenetic proteins (2)
- M05BX: Other drugs affecting bone structure and mineralization in ATC (7)
- M09: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC (13)
- M09A: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC (13)
- M09AA: Quinine and derivatives for DISORDERS OF THE MUSCULO-SKELETAL SYSTEM (2)
- M09AB: Enzymes FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM (4)
- M09AX: Other drugs for disorders of the musculo-skeletal system in ATC (7)
- N: NERVOUS SYSTEM DRUGS (611)
- N01: ANESTHETICS (59)
- N01A: ANESTHETICS, GENERAL (30)
- N01AA: Ethers for general anesthesia (2)
- N01AB: Halogenated hydrocarbons, general anesthetics (7)
- N01AF: Barbiturates for general anesthesia, plain (3)
- N01AG: barbiturates for general anesthesia, in combination with other drugs (1)
- N01AH: Opioid anesthetics (7)
- N01AX: Other general anesthetics in ATC (10)
- N01B: LOCAL ANESTHETICS (29)
- N01BA: Esters of aminobenzoic acid for local anesthesia (7)
- N01BB: Amide local anesthetics (17)
- N01BC: Esters of benzoic acid for local anesthesia (1)
- N01BX: Other local anesthetics in ATC (4)
- N02: ANALGESICS (132)
- N02A: OPIOID ANALGESICS (53)
- N02AA: Natural opium alkaloid analgesics (14)
- N02AB: Phenylpiperidine derivatives, opioid analgesics (5)
- N02AC: Diphenylpropylamine derivative analgesics (7)
- N02AD: Benzomorphan derivative analgesics (2)
- N02AE: Oripavine derivatives analgesics (1)
- N02AF: Morphinan derivatives, opiod analgesics (2)
- N02AG: Opioids in combination with antispasmodics (4)
- N02AG01: Morphine and antispasmodics
- N02AG02: Ketobemidone and antispasmodics
- N02AG03: Pethidine and antispasmodics
- N02AG04: Hydromorphone and antispasmodics
- N02AJ: Opioids in combination with non-opioid analgesics (13)
- N02AJ01: Dihydrocodeine and paracetamol
- N02AJ02: Dihydrocodeine and acetylsalicylic acid
- N02AJ03: Dihydrocodeine and other non-opioid analgesics
- N02AJ06: Codeine and paracetamol
- N02AJ07: Codeine and acetylsalicylic acid
- N02AJ08: Codeine and ibuprofen
- N02AJ09: Codeine and other non-opioid analgesics
- N02AJ13: Tramadol and paracetamol
- N02AJ14: Tramadol and dexketoprofen
- N02AJ15: Tramadol and other non-opioid analgesics
- N02AJ17: Oxycodone and paracetamol
- N02AJ18: Oxycodone and acetylsalicylic acid
- N02AJ19: Oxycodone and ibuprofen
- N02AX: Other opioids in ATC (5)
- N02B: OTHER ANALGESICS AND ANTIPYRETICS in ATC (56)
- N02BA: Salicylic acid and derivatives, analgesics and antipyretics (24)
- N02BB: Pyrazolones, analgesics and antipyretics (13)
- N02BE: Anilide analgesics and antipyretics (10)
- N02BG: Other analgesics and antipyretics in ATC (9)
- N02C: ANTIMIGRAINE PREPARATIONS (23)
- N02CA: Ergot alkaloids, antimigraine (7)
- N02CB: Corticosteroid derivatives, antimigraine drugs (1)
- N02CC: Selective serotonin (5HT1) agonists, antimigraine drugs (7)
- N02CD: Calcitonin gene-related peptide (CGRP) antagonists (3)
- N02CX: Other antimigraine preparations in ATC (5)
- N03: ANTIEPILEPTICS (48)
- N03A: ANTIEPILEPTICS (48)
- N03AA: Barbiturates and derivatives (5)
- N03AB: Hydantoin derivatives, antiepileptics (7)
- N03AC: Oxazolidine derivatives, antiepileptics (3)
- N03AD: Succinimide derivatives, antiepileptics (4)
- N03AE: Benzodiazepine derivative antiepileptics (1)
- N03AF: Carboxamide derivatives, antiepileptics (4)
- N03AG: Fatty acid derivatives, antiepileptics (6)
- N03AX: Other antiepileptics in ATC (18)
- N04: ANTI-PARKINSON DRUGS (37)
- N04A: ANTICHOLINERGIC AGENTS (14)
- N04AA: Tertiary amines, anticholinergic (10)
- N04AB: Ethers chemically close to antihistamines, anticholinergic (2)
- N04AC: Ethers of tropine or tropine derivatives, anticholinergic (2)
- N04B: DOPAMINERGIC AGENTS (23)
- N04BA: Dopa and dopa derivatives (6)
- N04BA01: Levodopa
- N04BA02: Levodopa and decarboxylase inhibitor
- N04BA03: Levodopa, decarboxylase inhibitor and COMT inhibitor
- N04BA04: Melevodopa
- N04BA05: Melevodopa and decarboxylase inhibitor
- N04BA06: Etilevodopa and decarboxylase inhibitor
- N04BB: Adamantane derivatives, dopaminergic (1)
- N04BC: Dopamine agonists (9)
- N04BD: MAO B Inhibitors, dopaminergic anti-parkinson drugs (3)
- N04BX: Other dopaminergic agents in ATC (4)
- N05: PSYCHOLEPTICS (177)
- N05A: ANTIPSYCHOTICS (67)
- N05AA: Phenothiazines with aliphatic side-chain, antipsychotics (7)
- N05AB: Phenothiazines with piperazine structure, antipsychotics (10)
- N05AC: Phenothiazines with piperidine structure, antipsychotics (4)
- N05AD: Butyrophenone derivatives, antipsychotics (9)
- N05AE: Indole derivatives, antipsychotic (5)
- N05AF: Thioxanthene derivatives, antipsychotic (5)
- N05AG: Diphenylbutylpiperidine derivatives, antipsychotics (3)
- N05AH: Diazepines, oxazepines, thiazepines and oxepines antipsychotic drugs (6)
- N05AL: Benzamide antipsychotics (7)
- N05AN: Lithium antipsychotics (1)
- N05AX: Other antipsychotics in ATC (10)
- N05B: ANXIOLYTICS (38)
- N05BA: Benzodiazepine derivative anxiolytics (24)
- N05BB: Diphenylmethane derivatives, anxiolytics (3)
- N05BC: Carbamate anxiolytics (4)
- N05BD: Dibenzo-bicyclo-octadiene derivative anxiolytics (1)
- N05BE: Azaspirodecanedione derivatives, anxiolytics (1)
- N05BX: Other anxiolytics in ATC (5)
- N05C: HYPNOTICS AND SEDATIVES (72)
- N05CA: Barbiturates, hypnotics and sedatives, plain (18)
- N05CB: Barbiturates, combinations (2)
- N05CB01: Combinations of barbiturates
- N05CB02: Barbiturates in combination with other drugs
- N05CC: Aldehydes and derivatives (5)
- N05CD: Benzodiazepine derivative hypnotics and sedatives (14)
- N05CE: Piperidinedione derivatives, hypnotics and sedatives (3)
- N05CF: Benzodiazepine related hypnotics and sedatives (4)
- N05CH: Melatonin receptor agonists, hypnotics and sedatives (3)
- N05CM: Other hypnotics and sedatives in ATC (17)
- N05CX: Hypnotics and sedatives in combination, excl. barbiturates (6)
- N06: PSYCHOANALEPTICS (113)
- N06A: ANTIDEPRESSANTS (64)
- N06AA: Non-selective monoamine reuptake inhibitors (21)
- N06AB: Selective serotonin reuptake inhibitors (9)
- N06AF: Monoamine oxidase inhibitors, non-selective (6)
- N06AG: MAO A Inhibitors, antidepressant drugs (2)
- N06AX: Other antidepressants in ATC (26)
- N06B: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS (36)
- N06BA: Centrally acting sympathomimetics (14)
- N06BC: Xanthine derivatives, psychostimulants, agents used for ADHD and nootropics (2)
- N06BX: Other psychostimulants and nootropics in ATC (20)
- N06C: PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION (3)
- N06CA: Antidepressants in combination with psycholeptics (3)
- N06CA01: Amitriptyline and psycholeptics
- N06CA02: Melitracen and psycholeptics
- N06CA03: Fluoxetine and psycholeptics
- N06CB: Psychostimulants in combination with psycholeptics (0)
- N06D: ANTI-DEMENTIA DRUGS (10)
- N06DA: Anticholinesterase anti-dementia drugs (7)
- N06DX: Other anti-dementia drugs in ATC (3)
- N06DX01: Memantine
- N06DX02: Ginkgo folium
- N06DX30: Other anti-dementia drug combinations in ATC
- N07: OTHER NERVOUS SYSTEM DRUGS in ATC (45)
- N07A: PARASYMPATHOMIMETICS (10)
- N07AA: Anticholinesterase parasympathomimetics (5)
- N07AB: Choline esters, parasympathomimetics (2)
- N07AX: Other parasympathomimetics in ATC (3)
- N07B: DRUGS USED IN ADDICTIVE DISORDERS (15)
- N07BA: Drugs used in nicotine dependence (3)
- N07BB: Drugs used in alcohol dependence (5)
- N07BC: Drugs used in opioid dependence (7)
- N07C: ANTIVERTIGO PREPARATIONS (5)
- N07CA: Antivertigo preparations (5)
- N07X: OTHER NERVOUS SYSTEM DRUGS in ATC (15)
- N07XA: Gangliosides and ganglioside derivatives (0)
- N07XX: Other nervous system drugs in ATC (15)
- P: ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS (128)
- P01: ANTIPROTOZOALS (69)
- P01A: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES (32)
- P01AA: Hydroxyquinoline derivatives for amoebiasis and other protozoal diseases (5)
- P01AB: Nitroimidazole derivatives, antiprotozoal agents against amoebiasis and other protozoal diseases (8)
- P01AC: Dichloroacetamide derivative drugs for amoebiasis and other protozoal diseases (4)
- P01AR: Arsenic compounds, for amoebiasis and other protozoal diseases (4)
- P01AX: Other agents against amoebiasis and other protozoal diseases in ATC (11)
- P01B: ANTIMALARIALS (25)
- P01BA: Aminoquinoline antimalarials (5)
- P01BB: biguanide antimalarials (3)
- P01BC: Methanolquinolines, antimalarial (2)
- P01BD: Diaminopyrimidines, antimalarials (2)
- P01BE: Artemisinin and derivatives, plain (5)
- P01BF: Artemisinin and derivatives, combinations (6)
- P01BF01: Artemether and lumefantrine
- P01BF02: Artesunate and mefloquine
- P01BF03: Artesunate and amodiaquine
- P01BF04: Artesunate, sulphamethopyrazine and pyrimethamine
- P01BF05: Artenimol and piperaquine
- P01BF06: Artesunate and pyronaridine
- P01BX: Other antimalarials in ATC (2)
- P01C: AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS (12)
- P01CA: Nitroimidazole derivatives, antiprotozoal agents against leishmaniasis and trypanosomiasis (2)
- P01CB: Antimony compounds for treatment of leishmaniasis and trypanosomiasis (2)
- P01CC: Nitrofuran derivatives, antiprotozoal drugs (2)
- P01CD: Arsenic compounds, for leishmaniasis and trypanosomiasis (2)
- P01CX: Other agents against leishmaniasis and trypanosomiasis in ATC (4)
- P02: ANTHELMINTICS (26)
- P02B: ANTITREMATODALS (7)
- P02BA: Quinoline derivatives and related substances, antitrematodals (2)
- P02BB: Organophosphorous compounds, antitrematodals (1)
- P02BX: Other antitrematodal agents in ATC (4)
- P02C: ANTINEMATODAL AGENTS (16)
- P02CA: Benzimidazole derivatives, antinematodal (7)
- P02CB: Piperazine and derivatives, antinematodal agents (2)
- P02CC: Tetrahydropyrimidine derivatives, antinematodal (2)
- P02CE: Imidazothiazole derivatives, antinematodal (1)
- P02CF: Avermectines (1)
- P02CX: Other antinematodals in ATC (3)
- P02D: ANTICESTODALS (3)
- P02DA: Salicylic acid derivative anticestodals (1)
- P02DX: Other anticestodals in ATC (2)
- P03: ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS (33)
- P03A: ECTOPARASITICIDES, INCL. SCABICIDES (23)
- P03AA: Sulfur containing product ectoparasiticides (6)
- P03AB: Chlorine containing product ectoparasiticides (3)
- P03AC: Pyrethrines, incl. synthetic compounds, ectoparasiticides, incl. scabicides (8)
- P03AX: Other ectoparasiticides, incl. scabicides in ATC (6)
- P03B: INSECTICIDES AND REPELLENTS (10)
- P03BA: Pyrethrines (4)
- P03BX: Other insecticides and repellents in ATC (6)
- R: RESPIRATORY SYSTEM DRUGS (389)
- R01: NASAL PREPARATIONS (63)
- R01A: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE (57)
- R01AA: Sympathomimetics, plain (14)
- R01AB: Sympathomimetics, combinations excl. corticosteroids (7)
- R01AC: Antiallergic nasal preparations for topical use, excl. corticosteroids (9)
- R01AD: Corticosteroid nasal preparations for topical use (17)
- R01AX: Other nasal preparations in ATC (10)
- R01B: NASAL DECONGESTANTS FOR SYSTEMIC USE (6)
- R01BA: Sympathomimetics (6)
- R02: THROAT PREPARATIONS (30)
- R02A: THROAT PREPARATIONS (30)
- R02AA: Antiseptic throat preparations (18)
- R02AB: Antibiotic throat preparations (5)
- R02AD: local anesthetic throat preparations (4)
- R02AX: Other throat preparations in ATC (3)
- R03: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (126)
- R03A: ADRENERGICS, INHALANTS (46)
- R03AA: Alpha- and beta-adrenoreceptor agonist inhalants (1)
- R03AB: Non-selective beta-adrenoreceptor agonist inhalants (2)
- R03AC: Selective beta-2-adrenoreceptor agonist inhalants (18)
- R03AH: Combinations of adrenergics (0)
- R03AK: Adrenergics inhalants in combination with corticosteroids or other drugs, excl. anticholinergics (13)
- R03AK01: Epinephrine and other drugs for obstructive airway diseases
- R03AK02: Isoprenaline and other drugs for obstructive airway diseases
- R03AK04: Salbutamol and sodium cromoglicate
- R03AK05: Reproterol and sodium cromoglicate
- R03AK06: Salmeterol and fluticasone
- R03AK07: Formoterol and budesonide
- R03AK08: Formoterol and beclometasone
- R03AK09: Formoterol and mometasone
- R03AK10: Vilanterol and fluticasone furoate
- R03AK11: Formoterol and fluticasone
- R03AK12: Salmeterol and budesonide
- R03AK13: Salbutamol and beclometasone
- R03AK14: Indacaterol and mometasone
- R03AL: Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids (12)
- R03AL01: Fenoterol and ipratropium bromide
- R03AL02: Salbutamol and ipratropium bromide
- R03AL03: Vilanterol and umeclidinium bromide
- R03AL04: Indacaterol and glycopyrronium bromide
- R03AL05: Formoterol and aclidinium bromide
- R03AL06: Olodaterol and tiotropium bromide
- R03AL07: Formoterol and glycopyrronium bromide
- R03AL08: Vilanterol, umeclidinium bromide and fluticasone furoate
- R03AL09: Formoterol, glycopyrronium bromide and beclometasone
- R03AL10: Formoterol and tiotropium bromide
- R03AL11: Formoterol, glycopyrronium bromide and budesonide
- R03AL12: Indacaterol, glycopyrronium bromide and mometasone
- R03B: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS in ATC (21)
- R03BA: Glucocorticoid inhalants for obstructive airway disease (9)
- R03BB: Anticholinergics inhalants for obstructive airway diseases (9)
- R03BC: Antiallergic inhalants for obstructive airway diseases, excl. corticosteroids (2)
- R03BX: Other drugs for obstructive airway diseases, inhalants in ATC (1)
- R03C: ADRENERGICS FOR SYSTEMIC USE (21)
- R03CA: Alpha- and beta-adrenoreceptor agonist, systemic drugs (1)
- R03CB: Non-selective beta-adrenoreceptor agonists for systemic use (5)
- R03CC: Selective beta-2-adrenoreceptor agonists, systemic (15)
- R03CK: Adrenergics systemic drugs and other drugs for obstructive airway diseases (0)
- R03D: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC (38)
- R03DA: Xanthines, systemic for obstructive airway disease (18)
- R03DB: Xanthines and adrenergics (6)
- R03DB01: Diprophylline and adrenergics
- R03DB02: Choline theophyllinate and adrenergics
- R03DB03: Proxyphylline and adrenergics
- R03DB04: Theophylline and adrenergics
- R03DB05: Aminophylline and adrenergics
- R03DB06: Etamiphylline and adrenergics
- R03DC: Leukotriene receptor antagonists for obstructive airway diseases (5)
- R03DX: Other systemic drugs for obstructive airway diseases in ATC (9)
- R05: COUGH AND COLD PREPARATIONS (70)
- R05C: EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS (28)
- R05CA: Expectorants (13)
- R05CB: Mucolytics (15)
- R05D: COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS (38)
- R05DA: Opium alkaloids and derivatives, cough suppressants (12)
- R05DB: Other cough suppressants in ATC (26)
- R05F: COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS (4)
- R05FA: Opium derivatives and expectorants (2)
- R05FA01: Opium derivatives and mucolytics
- R05FA02: Opium derivatives and expectorants
- R05FB: Other cough suppressants and expectorants in ATC (2)
- R05FB01: Cough suppressants and mucolytics
- R05FB02: Cough suppressants and expectorants
- R05X: OTHER COLD PREPARATIONS in ATC (0)
- R06: ANTIHISTAMINES FOR SYSTEMIC USE (82)
- R06A: ANTIHISTAMINES FOR SYSTEMIC USE (82)
- R06AA: Aminoalkyl ethers, systemic antihistamines (13)
- R06AB: Substituted alkylamines, systemic antihistamines (11)
- R06AC: Substituted ethylene diamines, systemic antihistamines (8)
- R06AD: Phenothiazine derivatives, systemic antihistamines (11)
- R06AE: Piperazine derivatives, systemic antihistamines (10)
- R06AK: Combinations of antihistamines (0)
- R06AX: Other antihistamines for systemic use in ATC (29)
- R07: OTHER RESPIRATORY SYSTEM PRODUCTS in ATC (18)
- R07A: OTHER RESPIRATORY SYSTEM PRODUCTS in ATC (18)
- R07AA: Lung surfactants (3)
- R07AB: Respiratory stimulants (11)
- R07AX: Other respiratory system products in ATC (4)
- S: SENSORY ORGAN DRUGS (287)
- S01: OPHTHALMOLOGICALS (236)
- S01A: ANTIINFECTIVE OPHTHALMOLOGICS (62)
- S01AA: Antibiotics, ophthalmologic (27)
- S01AB: Sulfonamides, ophthalmologic antiinfectives (5)
- S01AD: Antivirals, ophthalmologic (8)
- S01AE: Fluoroquinolone antiinfectives, ophthalmologic (8)
- S01AX: Other antiinfectives in ATC (14)
- S01B: ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC (30)
- S01BA: Corticosteroid ophthalmologic antiinflammatory agents, plain (15)
- S01BB: Corticosteroids and mydriatics in combination (4)
- S01BB01: Hydrocortisone and mydriatics
- S01BB02: Prednisolone and mydriatics
- S01BB03: Fluorometholone and mydriatics
- S01BB04: Betamethasone and mydriatics
- S01BC: Antiinflammatory agents, non-steroidal, ophthalmologic (11)
- S01C: ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION (18)
- S01CA: Corticosteroids and antiinfectives in combination, opthalmologic (11)
- S01CA01: Dexamethasone and antiinfectives
- S01CA02: Prednisolone and antiinfectives
- S01CA03: Hydrocortisone and antiinfectives
- S01CA04: Fluocortolone and antiinfectives
- S01CA05: Betamethasone and antiinfectives
- S01CA06: Fludrocortisone and antiinfectives
- S01CA07: Fluorometholone and antiinfectives
- S01CA08: Methylprednisolone and antiinfectives
- S01CA09: Chloroprednisone and antiinfectives
- S01CA10: Fluocinolone acetonide and antiinfectives
- S01CA11: Clobetasone and antiinfectives
- S01CB: Corticosteroids/antiinfectives/mydriatics in combination (5)
- S01CC: Antiinflammatory agents, non-steroids and antiinfectives in combination (2)
- S01CC01: Diclofenac and antiinfectives
- S01CC02: Indometacin and antiinfectives
- S01E: ANTIGLAUCOMA PREPARATIONS AND MIOTICS (45)
- S01EA: Sympathomimetics in glaucoma therapy (6)
- S01EB: Parasympathomimetics, antiglaucoma preparations and miotics (12)
- S01EC: Carbonic anhydrase inhibitors, antiglaucoma drugs and miotics (6)
- S01ED: Beta blocking agents, antiglaucoma preparations and miotics (10)
- S01EE: Prostaglandin analogues, antiglaucoma drugs and miotics (7)
- S01EX: Other antiglaucoma preparations in ATC (4)
- S01F: MYDRIATICS AND CYCLOPLEGICS (12)
- S01FA: Anticholinergic mydriatics and cycloplegics (8)
- S01FB: Sympathomimetics excl. antiglaucoma preparations (4)
- S01G: DECONGESTANTS AND ANTIALLERGICS (23)
- S01GA: Sympathomimetics used as decongestants (11)
- S01GX: Other antiallergics in ATC (12)
- S01H: Local anesthetics, ophthalmologic (8)
- S01HA: Local anesthetics (8)
- S01J: DIAGNOSTIC AGENTS, OPHTHAMOLOGIC (3)
- S01JA: Diagnostic, opthalmologic coloring agents (3)
- S01JX: Other ophthalmological diagnostic agents in ATC (0)
- S01K: SURGICAL AIDS, OPHTHALMOLOGIC (4)
- S01KA: Viscoelastic substances (3)
- S01KX: Other ophthalmologic surgical aids in ATC (1)
- S01L: OCULAR VASCULAR DISORDER AGENTS (6)
- S01LA: Antineovascularisation agents (6)
- S01X: OTHER OPHTHALMOLOGICALS IN ATC (25)
- S01XA: Other ophthalmologicals in ATC (25)
- S02: OTOLOGICALS (34)
- S02A: ANTIINFECTIVE DRUGS, OTOLOGIC (17)
- S02AA: Antiinfectives (17)
- S02B: Corticosteroid otologicals (5)
- S02BA: Corticosteroids (5)
- S02C: Corticosteroids and antiinfectives in combination, otologic (7)
- S02CA: Corticosteroids and antiinfectives in combination (7)
- S02CA01: Prednisolone and antiinfectives
- S02CA02: Flumetasone and antiinfectives
- S02CA03: Hydrocortisone and antiinfectives
- S02CA04: Triamcinolone and antiinfectives
- S02CA05: Fluocinolone acetonide and antiinfectives
- S02CA06: Dexamethasone and antiinfectives
- S02CA07: Fludrocortisone and antiinfectives
- S02D: OTHER OTOLOGICALS in ATC (5)
- S02DA: Analgesics and anesthetics (5)
- S02DC: Indifferent preparations, otologicals (0)
- S03: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS (17)
- S03A: ANTIINFECTIVES, OPHTHALMOLOGIC AND OTOLOGIC (9)
- S03AA: Antiinfectives (9)
- S03B: Corticosteroid ophthalmologic and otologic preparations (3)
- S03BA: Corticosteroids (3)
- S03C: Corticosteroids and antiinfectives in combination, opthalmologic and otologic (5)
- S03CA: Corticosteroids and antiinfectives in combination (5)
- S03CA01: Dexamethasone and antiinfectives
- S03CA02: Prednisolone and antiinfectives
- S03CA04: Hydrocortisone and antiinfectives
- S03CA05: Fludrocortisone and antiinfectives
- S03CA06: Betamethasone and antiinfectives
- S03D: OTHER OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS in ATC (0)
- V: VARIOUS DRUG CLASSES IN ATC (301)
- V01: ALLERGENS (11)
- V01A: ALLERGENS (11)
- V01AA: Allergen extracts (11)
- V01AA01: Feather
- V01AA02: Grass pollen
- V01AA03: House dust mites
- V01AA04: Mold fungus and yeast fungus allergenic extracts
- V01AA05: Tree pollen allergenic extracts
- V01AA07: Insect allergenic extracts
- V01AA08: Food allergenic extracts
- V01AA09: Textile allergenic extracts
- V01AA10: Flower allergenic extracts
- V01AA11: Animal allergen extracts
- V01AA20: Various allergen extracts
- V03: ALL OTHER THERAPEUTIC PRODUCTS (66)
- V03A: ALL OTHER THERAPEUTIC PRODUCTS (66)
- V03AB: Antidotes (32)
- V03AC: Iron chelating agents (3)
- V03AE: Drugs for treatment of hyperkalemia and hyperphosphatemia (10)
- V03AF: Detoxifying agents for antineoplastic treatment (11)
- V03AG: Drugs for treatment of hypercalcemia (1)
- V03AH: Drugs for treatment of hypoglycemia (1)
- V03AK: Tissue adhesives (0)
- V03AM: Drugs for embolisation (0)
- V03AN: Medical gases (5)
- V03AX: Other therapeutic products in ATC (2)
- V03AZ: Nerve depressant drugs (1)
- V04: DIAGNOSTIC AGENTS (42)
- V04B: URINE TEST DRUGS (0)
- V04C: OTHER DIAGNOSTIC AGENTS in ATC (42)
- V04CA: Diagnostic agents for diabetes testing (2)
- V04CB: diagnostic agents for fat absorption testing (1)
- V04CC: Diagnostic agents for bile duct patency testing (4)
- V04CD: pituitary function test diagnostic agents (5)
- V04CE: liver functional capacity test diagnostic agents (3)
- V04CF: Tuberculosis diagnostics agents (1)
- V04CG: gastric secretion test diagnostic agents (6)
- V04CH: renal function and ureteral injuries test diagnostic agents (5)
- V04CJ: thyreoidea function test diagnostic agents (2)
- V04CK: pancreatic function test diagnostic agents (3)
- V04CL: allergic disease test diagnostic agents (0)
- V04CM: fertility disturbances test diagnostic agents (1)
- V04CX: Other diagnostic agents in ATC (9)
- V06: GENERAL NUTRIENTS (2)
- V06A: DIET FORMULATIONS FOR TREATMENT OF OBESITY (0)
- V06AA: Low-energy diet formulations for treatment of obesity (0)
- V06B: PROTEIN SUPPLEMENTS (0)
- V06C: INFANT FORMULAS (0)
- V06CA: Nutrients without phenylalanine (0)
- V06D: OTHER NUTRIENTS in ATC (2)
- V06DA: Carbohydrates/proteins/minerals/vitamins, combinations (0)
- V06DB: Fat/carbohydrates/proteins/minerals/vitamins, combinations (0)
- V06DC: Carbohydrate nutrients (2)
- V06DD: Amino acids, incl. combinations with polypeptides (0)
- V06DE: Amino acids/carbohydrates/minerals/vitamins, combinations (0)
- V06DF: Milk substitutes (0)
- V06DX: Other combinations of nutrients in ATC (0)
- V07: ALL OTHER NON-THERAPEUTIC PRODUCTS (0)
- V07A: ALL OTHER NON-THERAPEUTIC PRODUCTS (0)
- V07AA: Plasters (0)
- V07AB: Solvents and diluting agents, incl. irrigating solutions (0)
- V07AC: Blood transfusion, auxiliary products (0)
- V07AD: Blood tests, auxiliary products (0)
- V07AN: Incontinence equipment (0)
- V07AR: Sensitivity tests, discs and tablets (0)
- V07AS: Stomi equipment (0)
- V07AT: Cosmetics (0)
- V07AV: Technical disinfectants (0)
- V07AX: Washing agents etc. (0)
- V07AY: Other non-therapeutic auxiliary products in ATC (0)
- V07AZ: Chemicals and reagents for analysis (0)
- V08: CONTRAST MEDIA (59)
- V08A: X-RAY CONTRAST MEDIA, IODINATED (36)
- V08AA: Watersoluble, nephrotropic, high osmolar X-ray contrast media (10)
- V08AB: Watersoluble, nephrotropic, low osmolar X-ray contrast media (12)
- V08AC: Watersoluble, hepatotropic X-ray contrast media (10)
- V08AD: Non-watersoluble X-ray contrast media (4)
- V08B: X-RAY CONTRAST MEDIA, NON-IODINATED (2)
- V08BA: Barium sulfate containing X-ray contrast media (2)
- V08BA01: Barium sulfate with suspending agents
- V08BA02: Barium sulfate without suspending agents
- V08C: MAGNETIC RESONANCE IMAGING CONTRAST MEDIA (15)
- V08CA: Paramagnetic contrast media (11)
- V08CB: Superparamagnetic contrast media (3)
- V08CX: Other magnetic resonance imaging contrast media in ATC (1)
- V08D: ULTRASOUND CONTRAST MEDIA (6)
- V08DA: Ultrasound contrast media (6)
- V09: DIAGNOSTIC RADIOPHARMACEUTICALS (102)
- V09A: CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS (10)
- V09AA: Technetium 99m compounds, central nervous system diagnostic radiopharmaceuticals (2)
- V09AB: Iodine I-123 compounds, CNS diagnostic radiopharmaceuticals (3)
- V09AX: Other central nervous system diagnostic radiopharmaceuticals in ATC (5)
- V09B: SKELETON DIAGNOSTIC RADIOPHARMACEUTICALS (4)
- V09BA: Technetium 99m compounds, skeletal system diagnostic radiopharmaceuticals (4)
- V09C: RENAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS (10)
- V09CA: Technetium 99m compounds, renal system diagnostic radiopharmaceuticals (6)
- V09CX: Other renal system diagnostic radiopharmaceuticals in ATC (4)
- V09D: HEPATIC AND RETICULO ENDOTHELIAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS (13)
- V09DA: Technetium 99m compounds, hepatic and reticulo endothelial system diagnostic radiopharmaceuticals (5)
- V09DB: Technetium 99m particles and colloid diagnostic radiopharmaceuticals for hepatic and reticulo endothelial system (7)
- V09DX: Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals in ATC (1)
- V09E: RESPIRATORY SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS (8)
- V09EA: Technetium (99mTc), inhalants (3)
- V09EB: Technetium (99mTc), particles for injection (2)
- V09EX: Other respiratory system diagnostic radiopharmaceuticals in ATC (3)
- V09F: THYROID DIAGNOSTIC RADIOPHARMACEUTICALS (4)
- V09FX: Various thyroid diagnostic radiopharmaceuticals (4)
- V09G: CARDIOVASCULAR SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS (13)
- V09GA: Technetium 99m compounds, cardiovascular system diagnostic radiopharmaceuticals (7)
- V09GB: Iodine I-125 compounds, cardivascular system diagnostic radiopharmaceuticals (2)
- V09GX: Other cardiovascular system diagnostic radiopharmaceuticals in ATC (4)
- V09H: INFLAMMATION AND INFECTION DETECTION (7)
- V09HA: Technetium 99m compounds, inflammation and infection detection radiopharmaceuticals (4)
- V09HA01: Technetium (99mTc) human immunoglobulin
- V09HA02: Technetium (99mTc) exametazime labelled cells
- V09HA03: Technetium (99mTc) antigranulocyte antibody
- V09HA04: Technetium (99mTc) sulesomab
- V09HB: Indium-111 inflammation and infection detection radiopharmaceuticals (2)
- V09HB01: Indium (111In) oxinate labelled cells
- V09HB02: Indium (111In) tropolonate labelled cells
- V09HX: Other diagnostic radiopharmaceuticals for inflammation and infection detection in ATC (1)
- V09I: TUMOUR DETECTION RADIOPHARMACEUTICALS (26)
- V09IA: Technetium 99m compounds, tumor detection radiopharmaceuticals (9)
- V09IB: Indium-111 tumour detection radiopharmaceuticals (4)
- V09IX: Other diagnostic radiopharmaceuticals for tumour detection in ATC (13)
- V09X: OTHER DIAGNOSTIC RADIOPHARMACEUTICALS in ATC (7)
- V09XA: Iodine I-131 diagnostic radiopharmaceuticals (3)
- V09XX: Various diagnostic radiopharmaceuticals (4)
- V10: THERAPEUTIC RADIOPHARMACEUTICALS (19)
- V10A: ANTIINFLAMMATORY THERAPEUTIC RADIOPHARMACEUTICALS (9)
- V10AA: Yttrium-90 antiinflammatory radiopharmaceuticals (3)
- V10AA01: Yttrium (90Y) citrate colloid
- V10AA02: Yttrium (90Y) ferrihydroxide colloid
- V10AA03: Yttrium (90Y) silicate colloid
- V10AX: Other antiinflammatory therapeutic radiopharmaceuticals in ATC (6)
- V10B: PAIN PALLIATION (BONE SEEKING AGENTS) (3)
- V10BX: Various pain palliation radiopharmaceuticals (3)
- V10X: OTHER THERAPEUTIC RADIOPHARMACEUTICALS in ATC (7)
- V10XA: iodine I-131 therapeutic radiopharmaceuticals (3)
- V10XX: Various therapeutic radiopharmaceuticals (4)
- V20: SURGICAL DRESSINGS (0)